▶ Explore this week’s Tape — live, sortable, drill-down →

A note from the desk: this week’s update is landing a few days late. We hit a technical problem over the weekend that took our production pipeline down. Everything below is as of Friday’s close, August 7. We’re back on the normal cadence next week. ## The Public Market Just Quoted a Price on a Drug Pipeline. The Price Was Zero.

Eighteen billion dollars of biotech changed hands inside seventy-two hours this week, and not one dollar of it was priced by the tape. That is the part worth sitting with. Not the premiums, not the CEO change, not the guidance cut. The fact that when a listed market and a private buyer looked at the same molecules on the same Monday, they came back with numbers that do not live in the same decade.

The cleanest evidence is an instrument almost nobody will look at. Curium is paying a hundred-two-fifty a share in cash for Lantheus at closing, plus up to twelve dollars a share in contingent value rights tied to clinical milestones, with the deal closing in the first half of 2027.¹ Lantheus finished the week around a hundred and one.² Read that as the market does: the cash is money-good, and the twelve dollars of clinical optionality is worth approximately nothing.

Approximately nothing.

That is not a Lantheus fact. It is a quoted, tradeable, sector-wide statement about what the public market will pay for radiopharmaceutical milestones it has not yet seen work, and the answer is that it will not pay. Every discounted-cash-flow argument about pipeline value in this space now has a live market print arguing against it, and the print says zero.

Meanwhile the buyers on the other side of that refusal are underwriting the exact same molecules at a discount rate the tape will not touch. Vertex beat the quarter, raised the year to roughly thirteen billion, and wrote a ten-billion-dollar cash check for Crinetics at eighty-five a share in the same week.³⁴⁵ It can do that because a franchise throwing off close to four billion of trailing free cash flow, marked in the Cash Flow Memo around thirty times, funds a decade-long option without going near the debt line.⁶⁷ Curium is private capital reaching the same conclusion through a different funding stack. Both transacted above where the listed market had the asset marked. The cashflow read is in Marcus’s column below; short version, Lantheus screens like a cash machine and now trades like a legal document.

And then BioNTech, which is the one that ratifies all of it. Seven times trailing free cash flow, a fourteen percent yield, a market that has effectively stopped underwriting a future at all.⁸⁹ Management’s answer was not to argue. It halved the revenue guide, replaced the co-founder in the CEO seat, said it would close manufacturing sites affecting up to eighteen hundred and sixty jobs, and authorized a billion-dollar buyback.¹⁰¹¹¹² That is a management team agreeing, in cash, with the tape’s refusal to fund its own pipeline.

Here is the second-order effect nobody put a number on this week. Every one of these transactions moves the option value of a drug pipeline off a public balance sheet and onto a private or strategic one, at the precise moment the public market has declared that optionality worthless. Public shareholders get the cash and forfeit the decade. That is not a premium — it is a settlement. Crinetics holders get eighty-five dollars today; Vertex gets whatever those molecules are in 2034. Lantheus holders get a hundred-two-fifty and a lottery ticket the market has already voided. The premium is the consolation prize for handing over the part that compounds.

What changes the read. Watch the contingent value right itself. It is a listed instrument that will trade between now and the close in the first half of 2027, and it is the only continuous public quote on radiopharmaceutical milestone risk anyone will get. If it develops a real bid, the public market is re-underwriting clinical optionality and this discount closes. If it sits at nothing through the close, the price-setting has moved permanently off the tape, and the next listed rare-disease or radiopharma name to go strategic or private goes at a premium the screens never marked. The other test is BioNTech’s oncology data, which is the only thing that separates a rational retreat at seven times from a market that got it wrong.

Wall Street’s consensus on biotech M&A: a premium is a win for shareholders. Ten billion in cash and a contingent value right nobody will bid for suggests the premium is what you get paid to stop owning the decade.

The Tape — W2632

Universe of 94 cashflow-memo names, snap dates 2026-07-31 → 2026-08-07. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

Lantheus ranks in the table above on cash flows that stopped setting its price this week. The composite reads it as a balanced cash generator, 8.2% FCF yield, top-five in the universe, and none of that is what clears the stock now. It is a legal document trading against $102.50 of cash at closing plus up to $12 a share in contingent value rights, and the tape is marking that $12 at approximately nothing. That is not laziness. Radiopharmaceutical milestones are clinical, not commercial, and the public market has never priced that risk well in either direction. The test between now and the first-half-2027 close is whether the CVR develops a real bid. A bid means someone is re-underwriting milestones the seller could not prove standing on its own.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

85 of 92 ranked-eligible names ranked. 7 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-08-07.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

Weekend Update - W2632

Why a Q2 beat bought nothing this week, and $18 billion of biotech changed hands

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the companies in the Cash Flow Memo. About 14 minutes. No filler.

Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2633.

Chapter markers

* Time | Segment

* 0:00 | Cold open — a good quarter bought nothing

* 0:45 | Theme — the quarter is a receipt (AMD, CVS, Celsius)

* 4:45 | Deep dive — page 15: Vertex, Lantheus, BioNTech

* 8:45 | Rapid fire — ConocoPhillips, Harrow, and the forward calendar

* 11:45 | Close, Consensus Watch, and the Wednesday tease

* 12:40 | Closing disclaimer

Full transcript

Cold open

Ava: A good quarter bought you nothing this week. The companies that beat got sold. The one that missed got an activist who wants the CEO’s job. And the biggest checks anyone wrote were for assets that don’t pay off until the 2030s — $18 billion of biotech changed hands inside 72 hours[^news-vrtx-crinetics-20260804][^news-lnth-curium-20260803]. Nobody was paying for the quarter. They were paying for the next five years. So today: two beats that got punished, one miss that turned into a proxy fight, and three companies on the same page of the memo making three incompatible bets on the same decade.

Ava: Telltales Weekend Update. I’m Ava Cabot, with Marcus Graham at the cashflow desk.

Theme — the quarter is a receipt

Ava: AMD delivered about as clean a print as semis produced this quarter, and the market took 7% out of the stock for it. Revenue $11.5 billion, up 52% year-over-year. Gross margin 54%. Net income $2.3 billion, EPS $1.30[^news-amd-q2-20260805]. Then the Q3 guide landed at $13.0 billion at the midpoint, above consensus[^news-amd-q3guide-20260805]. Beat, beat, and beat. Down 7%[^news-amd-stockdrop-20260805]. Marcus — what did they actually get punished for?

Marcus: Not the quarter. The price of admission. The memo had AMD at 88x trailing free cash flow going into this print, Q1 10-Q confirmed[^memo-amd-evfcf-20260807], on $8.7 billion of trailing free cash flow[^memo-amd-fcf-20260807]. We re-anchor when the Q2 10-Q files. At 88x you are not buying a beat, you are buying years of uninterrupted acceleration — and Jean Hu just told you the data center step-up is second-half weighted[^news-amd-datacenter-20260805]. Second-half weighted means the proof shows up after the multiple already has to hold. That’s the part that got sold.

Ava: And in the same week they went shopping. AMD agreed to buy Taalas, a Canadian startup, to add another category of AI silicon for the data center[^news-amd-taalas-20260806]. Marcus, is that a company that thinks it’s ahead?

Marcus: It’s a company hedging its own roadmap, which is the correct thing to do and an uncomfortable thing to watch. Going into this print the memo had AMD running $1.2 billion of capex trailing twelve[^memo-amd-capex-20260807] against under $1 billion of buybacks[^memo-amd-buyback-20260807], Q1 10-Q confirmed — and that was before Taalas. Lisa Su spent the week praising Elon Musk after SpaceX committed to Nvidia exclusively[^news-amd-musk-20260805]. Buying a second accelerator architecture says management does not believe one roadmap wins this market outright. That is honest, and it is the opposite of what a multiple in the high 80s is underwriting. The test is whether the Taalas silicon shows up in a customer deployment before that multiple has to be defended again.

Ava: Gracious in public, hedging in the checkbook. CVS beat the quarter, raised the year, then said one thing about 2027 and gave it all back. Adjusted EPS guidance up to $7.90–$8.10, from $7.30–$7.50[^news-cvs-q2guide-20260805]. $2 billion of costs already out the door, stores closed, leadership reshuffled[^news-cvs-costs-20260805]. And then a preliminary look at 2027 profit that disappointed, plus a warning about the pharmacy benefit business next year. Shares fell[^news-cvs-2027-20260805]. Marcus — twelve months of execution against one sentence about a year that hasn’t started.

Marcus: On this balance sheet, the sentence should win. The memo had CVS at 16x trailing free cash flow going in, Q1 10-Q confirmed[^memo-cvs-evfcf-20260807], carrying 7.5 turns of debt to free cash flow[^memo-cvs-debtfcf-20260807]. That leverage is what makes a 2027 comment expensive — a levered turnaround gets paid for the trajectory, not for the print. What would change my view is the pharmacy benefit line holding through next year’s renewal cycle. If it doesn’t, the deleveraging slides a year to the right, and the multiple is the thing doing the waiting.

Ava: And then Celsius, where a missed quarter turned into a job application. Q2 revenue $817.9 million against consensus of $870 million[^news-celh-revenue-20260806]. GAAP EPS down to $0.14 from $0.33 a year ago[^news-celh-eps-20260805]. The core Celsius brand shrank about 12%[^news-celh-brand-20260806]; Alani Nu retail sales grew 56%[^news-celh-alani-20260806]. So the growth is real. It’s just not the name on the can, and it’s not the name on the building. Adjusted EPS came in at $0.36, so the operating business is not broken[^news-celh-adjeps-20260805] — what’s broken is the story that Celsius, the brand, is the growth engine. Then Friday. Russ Savage, the man who founded Rockstar Energy, disclosed a 4.7% stake, more than 12 million shares, and said the board should replace CEO John Fieldly[^news-celh-savage-20260807]. With himself. Nobody buys 12 million shares of a company to relitigate last quarter. He’s buying the next five years of a portfolio he thinks is being run by the wrong person — and he built a competitor in this exact category before he bought a share of this one[^news-celh-savage-20260807].

Deep dive — page 15: Vertex, Lantheus, BioNTech

Ava: Page 15 of the Cash Flow Memo is pharma and biotech, and this week three names on that one page made three completely different bets on the same decade. Vertex is buying. Lantheus is being bought. BioNTech is shrinking.

Ava: Vertex beat, with Q2 revenue of $3.33 billion, up 12%[^news-vrtx-q2rev-20260803], raised full-year guidance to $13.1–$13.2 billion[^news-vrtx-guidance-20260804], and agreed to pay $10 billion in cash for Crinetics at $85 a share[^news-vrtx-crinetics-20260804]. Lantheus agreed to sell itself to Curium for up to $8 billion — $102.50 a share in cash at closing, plus up to $12 a share in contingent value rights, closing in the first half of 2027[^news-lnth-curium-20260803]. And BioNTech cut full-year revenue guidance from €2.5–€3.1 billion down to €1.6–€1.9 billion[^news-bntx-guidance-20260804], named Guido Oelkers to replace co-founder Ugur Sahin as CEO[^news-bntx-ceo-20260803], and said it will close manufacturing sites affecting up to 1,860 jobs while authorizing a $1 billion buyback[^news-bntx-layoffs-20260805]. Marcus — three answers to the same question. Which one is the market getting wrong?

Marcus: Lantheus, and the spread tells you where. The stock closed the week around $101[^memo-lnth-price-20260807] against $102.50 of cash at closing[^news-lnth-curium-20260803]. That’s a market saying the deal closes, and pricing the $12 of contingent value rights at approximately nothing. In radiopharmaceuticals the milestones are clinical, not commercial. A CVR with no bid is the market’s statement about what the buyer thinks it’s getting, and what the seller could never prove standing on its own.

Ava: Free option, no bid. And Vertex is standing on the other side of that trade.

Marcus: Vertex is paying cash for a pipeline it can’t sell for years, and it can afford to. The memo had Vertex at 30x trailing free cash flow going into the print, Q1 10-Q confirmed[^memo-vrtx-evfcf-20260807], on $3.7 billion of trailing free cash flow[^memo-vrtx-fcf-20260807]. $10 billion out the door against that clears without touching the debt line. We re-anchor when the Q2 10-Q files. What I’d watch is whether the raised guide survives the integration year, because a company that raises the year and writes the biggest check in its history in the same week is telling you the core franchise is funding the option, not the other way around.

Marcus: BioNTech is the one nobody wants to look at, and it’s the most honest of the three. Going into this print the memo had them at 7x trailing free cash flow[^memo-bntx-evfcf-20260807] at a 14% yield[^memo-bntx-fcfyield-20260807], Q1 10-Q confirmed, and those are euros, translated in the memo at today’s rate. That is a market that has stopped underwriting a future at all. Halving the guide, closing plants, and authorizing a buyback is management agreeing with that price. I’d weight it as a rational retreat rather than a value trap — but the two look identical until the oncology pipeline delivers data.

Ava: So what does page 15 actually say this week?

Marcus: That the discount rate on a biotech pipeline is being set by somebody other than the public market. Vertex at 30x trailing free cash flow and BioNTech at 7x sit on that same page[^memo-vrtx-evfcf-20260807][^memo-bntx-evfcf-20260807], applied to the same underlying activity — finding molecules that work. Curium is private capital, Vertex is a strategic, and both transacted above where the tape had the asset marked. When the price-setters on a page are a private buyer and a strategic buyer, the listed multiple stops being the opinion that matters. What would flip that is the Lantheus CVR trading with a real bid before the close.

Ava: Same page, same week, same disease franchises. One company spent $10 billion buying a decade. One took $102.50 a share to hand its decade to somebody else. One said out loud that it doesn’t have one to sell. Three managements priced their own optionality in public inside 72 hours. The earnings reactions were the small part.

Rapid fire

Ava: Rapid fire. ConocoPhillips posted its best profit since 2022 and used the same press cycle to change CEOs[^news-cop-profit-20260806]. Q2 earnings of $3.23 a share[^news-cop-q2eps-20260806]. Ryan Lance is out after 14 years into a transitional executive chair role; CFO Andy O’Brien becomes president and CEO September 1, with Konnie Haynes-Welsh moving up to CFO[^news-cop-succession-20260806]. Going into the print, the memo had Conoco at 9x trailing free cash flow[^memo-cop-evfcf-20260807] at a 10.8% yield[^memo-cop-fcfyield-20260807], on $18.5 billion of trailing free cash flow[^memo-cop-fcf-20260807]. That trailing twelve carried $4.0 billion of dividends and $4.5 billion of buybacks[^memo-cop-dividend-20260807][^memo-cop-buyback-20260807]. Handing a franchise returning that much capital to the finance seat at the top of the cycle is a choice. The thing to watch is whether the return pace survives the handoff, because a new CEO who came up through the CFO’s chair has every incentive to build a war chest in his first year.

Ava: Harrow bought a product four days before it has to explain itself. Definitive agreement for the global rights to Tyrvaya from Viatris — $30 million up front, up to $70 million more in milestones tied to net sales[^news-hrow-tyrvaya-20260806]. Tyrvaya is the only FDA-approved nasal spray for dry eye disease[^news-hrow-tyrvaya-fda-20260806]. On page 20 of the memo, Harrow sits at 46x trailing free cash flow[^memo-hrow-evfcf-20260807] with 8 turns of debt to free cash flow[^memo-hrow-debtfcf-20260807], Q1 10-Q confirmed. And Harrow reports Monday, consensus at a $0.23 loss on $70.4 million of revenue[^earn-hrow]. A levered specialty pharma company buying a commercial asset the week of its own print is either conviction or timing. Monday says which.

Ava: Also on page 20. Uber grew gross bookings 22%[^news-uber-bookings-20260804] and non-GAAP operating income 40%[^news-uber-opinc-20260804], then guided Q3 light and dropped 5%[^news-uber-guidance-20260805] — the same week it committed more than $10 billion to a robotaxi aggregator strategy[^news-uber-robotaxi-20260806]. And Airbnb beat and raised full-year revenue guidance to at least mid-teens growth[^news-abnb-guidance-20260807], with the stock up 15%[^news-abnb-surge-20260807] on a World Cup travel surge[^news-abnb-worldcup-20260807]. Brian Chesky says the company will spend a lot more on AI this year because inference came in cheaper than he budgeted for[^news-abnb-ceoai-20260807]. Which is a CEO announcing his own forecast was wrong, in the happiest available way.

Ava: Two more. Palantir grew US commercial revenue 149% to $764 million[^news-pltr-commercial-20260804], total revenue 93%[^news-pltr-total-20260804], raised the year to 82% growth[^news-pltr-fyguide-20260804], and put up 29% in a single session[^news-pltr-surge-20260804]. The memo had it at 102x trailing free cash flow before any of that, Q1 10-Q confirmed[^memo-pltr-evfcf-20260807]. 102x. Alex Karp’s line on the call was that his customers have, quote, declined to become vassal states of the language labs[^news-pltr-karp-20260804]. Nobody has ever sold sovereignty harder, and at 102x, nobody has ever needed to. And Disney beat on fiscal Q3[^news-dis-q3-20260805], sold its 50% stake in A+E Global Media to Hearst for $1.2 billion[^news-dis-ae-20260805], and signed a global short-form content deal with TikTok[^news-dis-tiktok-20260806] — three storylines, one week. Disney is selling the cable asset and renting the attention.

Ava: Forward calendar. Harrow Monday[^earn-hrow]. Venture Global Tuesday[^earn-vg]. Then the consumer block the week after — Home Depot Tuesday[^earn-hd], Lowe’s and Target Wednesday[^earn-low][^earn-tgt], Walmart and Deere Thursday[^earn-wmt][^earn-de]. Five names, three days, and the whole picture on household spending.

Close

Ava: That’s the show. A good quarter bought nothing this week. Wall Street’s consensus on earnings season: a beat gets bought. AMD beat on revenue, profit, and the guide and lost 7%. CVS beat and raised and gave it back on one sentence about 2027. Consensus is still grading last quarter’s tape.

Ava: What actually got paid for this week was the 2030s — $10 billion for Crinetics, up to $8 billion for Lantheus, $100 million for a single nasal spray. The prints were the receipts.

Ava: On Wednesday’s episode 2632, Hunt, Jason, and Mike took Harrow through the AI-in-healthcare segment and landed on it as a commercialization business, one where AI isn’t the deciding factor[^ep-e2632]. Four days later Harrow went out and bought something to commercialize. Hunt, Jason, and Mike are back Wednesday on episode 2633.

Ava: Download the memo at telltales.us. Twenty pages, every week. And send us feedback through the Substack. Every note gets seen.

Ava: The show is produced entirely with AI tools, and both voices you’re hearing are AI-generated.

Closing disclaimer

Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you. The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.

Sources

* Advanced Micro Devices. (2026, August 5). AMD reports second quarter 2026 financial results [Press release]. https://ir.amd.com/news-events/press-releases/detail/1295/amd-reports-second-quarter-2026-financial-results

* Associated Press. (2026, August 7). New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine. AP News. https://apnews.com/article/flu-vaccine-moderna-mrna-fda-mflusiva-59d991a6bf70c26e2f0c210cc8ca87f1

* Automotive World. (2026, August 6). Uber pledges $10bn to robotaxis, Waymo still important. Automotive World. https://www.automotiveworld.com/news/uber-pledges-10bn-to-robotaxis-waymo-still-important/

* Axios. (2026, August 5). Disney selling A+E stake, announces partnership with TikTok. Axios. https://www.axios.com/2026/08/05/disney-ea-hearst-cable-tv

* BioNTech. (2026, August 3). BioNTech announces appointment of Guido Oelkers to management board as Chief Executive Officer [Press release]. https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2026/08/BioNTech-Announces-Appointment-of-Guido-Oelkers-to-Management-Board-as-Chief-Executive-Officer.html

* BioNTech. (2026, August 4). BioNTech announces second quarter 2026 financial results and corporate update [Press release]. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-second-quarter-2026-financial-results-and

* Bloomberg. (2026, August 5). CVS Health falls after warning on 2027 outlook, Caremark challenges. Bloomberg. https://www.bloomberg.com/news/articles/2026-08-05/cvs-raises-outlook-as-medical-cost-improvement-drives-profits

* Bloomberg. (2026, August 6). Advanced Micro Devices to buy startup Taalas for new AI chips. Bloomberg. https://www.bloomberg.com/news/articles/2026-08-06/advanced-micro-devices-to-buy-startup-taalas-for-new-ai-chips

* Celsius Holdings, Inc. (2026, August 5). Celsius Holdings reports second quarter 2026 financial results [Press release]. https://ir.celsiusholdingsinc.com/news/news-details/2026/Celsius-Holdings-Reports-Second-Quarter-2026-Financial-Results/default.aspx

* CNBC. (2026, August 4). Palantir (PLTR) earnings Q2 2026. CNBC. https://www.cnbc.com/2026/08/03/palantir-pltr-earnings-q2-2026.html

* CNBC. (2026, August 4). Palantir stock skyrockets 29%, narrowly missing its best day ever after otherworldly results. CNBC. https://www.cnbc.com/2026/08/04/palantir-2q-earnings-ai-sovereign-tools.html

* CNBC. (2026, August 5). AMD earnings report Q2 2026. CNBC. https://www.cnbc.com/2026/08/04/amd-earnings-report-q2-2026.html

* CNBC. (2026, August 5). CVS Health (CVS) earnings Q2 2026. CNBC. https://www.cnbc.com/2026/08/05/cvs-health-cvs-earnings-q2-2026.html

* CNBC. (2026, August 5). Disney (DIS) earnings Q3 2026. CNBC. https://www.cnbc.com/2026/08/05/disney-dis-earnings-q3-2026.html

* CNBC. (2026, August 5). Lisa Su brushes off Musk’s Nvidia commitment as AMD stock sinks after earnings. CNBC. https://www.cnbc.com/2026/08/05/amd-stock-today-earnings-q2.html

* CNBC. (2026, August 5). Uber stock sinks 5% after weak guidance despite revenue growth. CNBC. https://www.cnbc.com/2026/08/05/uber-stock-q2-2026-earnings.html

* CNBC. (2026, August 6). Airbnb raises its outlook as growth accelerates and AI speeds product development [Video]. CNBC. https://www.cnbc.com/video/2026/08/06/airbnb-raises-its-outlook-as-growth-accelerates-and-ai-speeds-product-development.html

* CNBC. (2026, August 6). ConocoPhillips CEO Ryan Lance departs as oil producer posts best profit since 2022. CNBC. https://www.cnbc.com/2026/08/06/conocophillips-ceo-ryan-lance-departs-as-oil-producer-posts-best-profit-since-2022.html

* CNBC. (2026, August 7). Chesky says Airbnb will spend a lot more on AI as earnings beat and stock surges 15%. CNBC. https://www.cnbc.com/2026/08/07/chesky-airbnb-ai-earnings.html

* CNBC. (2026, August 7). Rockstar Energy founder builds Celsius stake, wants to take over as CEO. CNBC. https://www.cnbc.com/2026/08/07/rockstar-energy-founder-celsius-stake-ceo.html

* ConocoPhillips. (2026, August 6). ConocoPhillips announces planned leadership succession: Andy O’Brien named president and CEO, Ryan Lance to assume transitional executive chair role, Konnie Haynes-Welsh appointed CFO [Press release]. https://www.conocophillips.com/news-media/story/conocophillips-announces-planned-leadership-succession-andy-obrien-named-president-and-ceo-ryan-lance-to-assume-transitional-executive-chair-role-konnie-haynes-welsh-appointed-cfo/

* ConocoPhillips. (2026, August 6). ConocoPhillips announces second-quarter 2026 results and quarterly dividend [Press release]. https://www.conocophillips.com/news-media/story/conocophillips-announces-second-quarter-2026-results-and-quarterly-dividend/

* CVS Health. (2026, August 5). CVS Health Corporation reports strong second quarter 2026 results and raises full-year 2026 guidance [Press release]. https://www.cvshealth.com/news/company-news/cvs-health-corporation-reports-strong-second-quarter-2026-results-and-raises-full-year-2026-guidance.html

* Globe Newswire. (2026, August 6). Harrow acquires global rights to TYRVAYA, the first and only FDA-approved nasal spray for dry eye disease [Press release]. https://www.globenewswire.com/news-release/2026/08/06/3340081/0/en/harrow-acquires-global-rights-to-tyrvaya-the-first-and-only-fda-approved-nasal-spray-for-dry-eye-disease.html

* Invezz. (2026, August 7). Airbnb stock jumps 11% as World Cup travel sparks a surprise growth burst. Invezz. https://invezz.com/news/2026/08/07/airbnb-stock-jumps-11-as-world-cup-travel-sparks-a-surprise-growth-burst/

* Lantheus Holdings. (2026, August 3). Curium announces definitive agreement to merge with Lantheus [Press release]. https://investor.lantheus.com/news-releases/news-release-details/curium-announces-definitive-agreement-merge-lantheus

* Ophthalmology Times. (2026, August 7). Harrow acquires global rights to Tyrvaya. Ophthalmology Times. https://www.ophthalmologytimes.com/view/harrow-acquires-global-rights-to-tyrvaya

* Palantir Technologies. (2026, August 4). Q2 2026 press release [Exhibit 99.1]. U.S. Securities and Exchange Commission EDGAR. https://www.sec.gov/Archives/edgar/data/1321655/000132165526000039/a2026q2ex991pressrelease.htm

* Reuters. (2026, August 3). Palantir lifts annual revenue forecast on steady demand. Reuters. https://reuters.com/technology/palantir-raises-annual-revenue-forecast-strong-demand-us-government-commercial-2026-08-03

* Reuters. (2026, August 5). BioNTech SE company page: manufacturing site closures and $1.0 billion buyback authorization. Reuters. https://www.reuters.com/company/biontech-se/

* StockAnalysis. (2026, August 6). Celsius Holdings (CELH) stock price & overview. StockAnalysis. https://stockanalysis.com/stocks/celh/

* StockTitan. (2026, August 4). Crinetics (Nasdaq: CRNX) agrees to $85 cash-per-share sale to Vertex [8-K material event]. StockTitan. https://www.stocktitan.net/sec-filings/CRNX/8-k-crinetics-pharmaceuticals-inc-reports-material-event-3bad8e8db9de.html

* The Walt Disney Company. (2026, August 6). The Walt Disney Company and TikTok announce a first-of-its-kind global short-form content-sharing deal [Press release]. https://thewaltdisneycompany.com/news/tiktok-content-sharing-deal/

* TradingKey. (2026, August 5). AMD beat on revenue, profit, and guidance — So why did the stock drop 7%? TradingKey. https://www.tradingkey.com/analysis/stocks/us-stocks/262074451-amd-q2-2026-earnings-double-beat-stock-falls-tradingkey

* Uber Technologies. (2026, August 4). Uber announces results for second quarter 2026 [Press release]. https://investor.uber.com/news-events/news/press-release-details/2026/Uber-Announces-Results-for-Second-Quarter-2026/default.aspx

* Vertex Pharmaceuticals. (2026, August 3). Vertex reports second quarter 2026 financial results [Press release]. https://news.vrtx.com/news-releases/news-release-details/vertex-reports-second-quarter-2026-financial-results

* Yahoo Finance. (2026, August 4). Vertex Pharmaceuticals Inc (VRTX) (Q2 2026) earnings call highlights: Revenue surges 12%. Yahoo Finance. https://finance.yahoo.com/healthcare/articles/vertex-pharmaceuticals-inc-vrtx-q2-050826035.html

* Yahoo Finance. (2026, August 6). Celsius Q2 earnings call highlights. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/celsius-q2-earnings-call-highlights-130400635.html

* Yahoo Finance UK. (2026, August 6). Celsius Holdings Inc (CELH) (Q2 2026) earnings call highlights: Portfolio growth drives 11%. Yahoo Finance UK. https://uk.finance.yahoo.com/news/celsius-holdings-inc-celh-q2-190423226.html

Note: reference 2 (AP News) is retained from the dryrun source pool and is not cited in the shipped script. All other entries map to at least one footnote in the canonical.

Internal data

Internal data is provided on a best efforts basis.

Earnings slate

Forward earnings dates are sourced from the W2632 earnings slate, pulled 2026-08-07. See 04. Publishing/shows/weekend-update/W2632/dryrun/earnings_slate.md.

* DE - Deere & Company, 2026-08-20 (Thursday), consensus EPS 4.71, consensus revenue $10.8B

* HD - Home Depot, 2026-08-18 (Tuesday), consensus EPS 4.73, consensus revenue $47.3B

* HROW - Harrow Inc, 2026-08-10 (Monday), consensus EPS -0.23, consensus revenue $70.4M

* LOW - Lowe’s, 2026-08-19 (Wednesday), consensus EPS 4.25, consensus revenue $26.2B

* TGT - Target, 2026-08-19 (Wednesday), consensus EPS 2.30, consensus revenue $26.1B

* VG - Venture Global, 2026-08-11 (Tuesday), consensus EPS 0.48, consensus revenue $4.7B

* WMT - Walmart, 2026-08-20 (Thursday), consensus EPS 0.74, consensus revenue $186.8B

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Mike, and Jason walk the Cash Flow Memo through an oil tape driven by Hormuz headlines, a power grid that has started saying no to data centers, and the valuation question underneath the Tesla-SpaceX merger.

The Cashflow Memo

Key Takeaways

* Oil is trading the Hormuz headline, not the fundamentals: Saudi Aramco earned $33B in Q2 because price more than offset shipped volume, and its CEO says ~2 mmbbl/d of Saudi supply covers customers with or without the Strait open. Hunt’s pattern holds (roughly $90 on missile strikes, high-$70s to $80 when calm, ~$20 of backwardation to the 12-month strip at ~$70-72), and he reads the market as pricing this better than the commentators do.

* Natural gas is holding $3.50 on LNG alone (13 Bcf/d in 2024, 16 in 2025, 18+ this year, 20 next) with gas-for-power flat since 2025; the swing factor is data centers forcing on-site turbines, which would restore ~1.5 Bcf/d/yr of power demand and firm gas toward $4. Supply growth is 10 of the last 15 Bcf/d from Permian associated gas, so incremental supply keys off the oil price, not the gas price.

* Siting, not chips, is now the binding constraint on the buildout: New York has a one-year hold, Virginia is saturated (Google will not propose more), and the Texas governor just ordered audits (effectively ~12 months) of 900 GW of proposals against ~90 GW of installed state capacity. Combined cycle cannot be built fast enough and turbines are sold out, so on-site generation is the only path.

* SpaceX is the episode’s central valuation debate: hosts expect Tesla merged into SpaceX on a trailing-45-day price basis after the China operations are spun out, and treat the equity as a data center business that buys land-free siting. Jason underwrites just south of $90 (~8 GW next year at ~$35B/GW, 20 GW target, 15% IRR), Hunt anchors $50 at roughly half the current price, and Mike flags lockup expiries and launch or regulatory stumbles as the cheaper entry. Launch economics gate the space leg: $1,000/kg makes a gigawatt cost $31B to loft, $150/kg makes it $4.7B, and Starship has flown four times.

* Healthcare AI expands capability rather than cutting cost, with one exception. Lilly’s Isomorphic Labs partnership is about a year old with nothing to show yet, and scientists at Lilly, Regeneron, and Pfizer will assault IT budgets for tokens rather than save money. UnitedHealth is the real cost-out: $1.5B of IT spend, one-third to make Optum Insight AI-first and two-thirds to insurance systems, with a pre-auth pilot cutting missing-information denials 68% and appeals nearly 90%. Energy IT departments (Exxon, midstream, EOG) get genuine savings, and the token spend routes through Amazon, Microsoft, and Google because no one gets fired for running a Chinese open-weight model on a hyperscaler.

Show Notes

[00:00] Intro & Cash Flow Memo Download the memo at telltales.us; 30 minutes on energy, technology, and healthcare cash flows.

[00:27] Iran, Hormuz, and $90 Oil Saudi Aramco earned $33B in Q2 as price offset lost volume, and management says ~2 mmbbl/d covers customers either way. Oil runs to roughly $90 on strikes and back to the high-$70s when things calm, with ~$20 of backwardation to the 12-month strip.

[03:19] Exhibit B: Gas, LNG, and Permian Supply Gas holds $3.50 on LNG growth from 13 Bcf/d in 2024 to 20 next year, while gas-for-power has been flat since 2025. Ten of the last 15 Bcf/d of supply growth is Permian associated gas, so supply follows the oil price.

[05:01] The Grid Says No: New York, Texas, Virginia New York’s one-year hold, Virginia’s saturation, and the Texas governor’s audit letter against 900 GW of proposals versus ~90 GW of state capacity. Combined cycle is too slow and turbines are sold out, so on-site generation wins.

[10:40] Tesla into SpaceX: What Is It Worth The hosts expect a trailing-45-day merger after a China spin-out, then split on price: Jason just south of $90 on 8 GW next year at ~$35B/GW and a 15% IRR, Hunt at $50, Mike waiting on lockups and launch risk. Launch cost decides the space leg at $31B versus $4.7B per gigawatt.

[18:18] AI in Healthcare: Harrow, Lilly, UnitedHealth Harrow is a commercialization business where AI is not decisive. Lilly’s Isomorphic Labs tie-up is a year old with no results yet. UnitedHealth is spending $1.5B, with a pre-auth pilot cutting missing-information denials 68% and appeals nearly 90%.

[22:53] Token Budgets at Pfizer and Regeneron Scientists will consume the IT budget rather than shrink it. Expect more candidates and fewer late failures, not cost savings.

[24:20] Energy IT: Exxon, Midstream, EOG Upstream and midstream have run machine learning for years and get real cost savings here. EOG’s decade-old well-file system is the template.

[26:12] Open Weights and Why the Hyperscalers Win Open-weight models cut token cost, but IT departments would rather buy from Amazon, Microsoft, and Google than defend a Chinese model to their board. That routes the savings through the hyperscalers.

[28:06] Apple’s Siri Problem Apple still has no AI-enabled phone and a software team behind the eight ball. Ecosystem lock-in buys time; it does not buy stagnation.

Subscribe for the weekly Cash Flow Memo walkthrough, download the memo at telltales.us, and join us next Wednesday.

Cashtags

$AAPL $AMZN $EOG $GOOGL $HROW $ILMN $KMI $LLY $MSFT $PFE $REGN $SPCX $TSLA $UNH $XOM

This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →

Microsoft Bought Twenty Years of Power. The Market Graded the Buyer.

The AI build spent this week being graded on the buyer’s income statement. The most consequential thing that happened to it was signed by a seller. Chevron agreed to supply Microsoft with two-point-six-seven gigawatts of behind-the-meter power at a West Texas data center, for twenty years, disclosed inside Chevron’s own second-quarter release.¹ Twenty years. In a week the market spent deciding whether Microsoft’s spending was disciplined and Meta’s was reckless, one of them committed to a two-decade fixed obligation that lands on neither company’s capex line.

Start with what a behind-the-meter contract actually is, because the phrase is doing real work. The power never touches the public grid. It is generated on site and delivered straight into the data center, which means Microsoft is not waiting in an interconnection queue and is not buying at a utility tariff that moves. It is buying a fixed claim on generation through 2046. That is not capital expenditure. It does not show up in the capex line the entire market spent the week staring at, it does not depress free cash flow in the quarter it is signed, and it does not appear on any screen sorting hyperscalers by how fast the revenue is catching the build.

Which is the same maneuver, in a different costume, as the fourteen-billion-dollar data center venture Meta struck with BlackRock three days earlier.² Both companies are moving the build off their own cash flow statement. One did it with a joint venture and one did it with an offtake contract, and both were signed by companies whose stocks the market was busy re-rating on precisely the cash flow statements the deals are designed to bypass. The show asked who got paid this week. The answer neither company put in a headline is that the counterparties did.

Now look at where those counterparties sit on this week’s Tape. Energy carries the lowest expected forward revenue growth of the ten sectors on the board, barely above zero, and the second-worst median composite score in the universe. The screens price the sector as structurally ex-growth. The screens are reading a strip. The strip does not know that the marginal buyer of new American electricity is now a company with a compute deadline and a balance sheet that makes twenty-year commitments look cheap.

Be precise about the size, because the size is not the argument. Chevron earned twelve-point-one billion dollars in the quarter, six dollars and eleven cents a share, up nearly four hundred percent year over year.³ Against that, one power contract is a rounding error, and it will be one for years. What is not a rounding error is the precedent: a supermajor just booked two decades of investment-grade contracted demand for a product the market values at spot. The rest of Chevron stays exactly what it was, priced off the same cyclical molecules, and CEO Eimear Bonner told Bloomberg she expects fuel-making margins to stay high for as long as energy markets remain, quote, under stress.⁴ Under stress. That is a CEO describing the best margin environment she has, in the vocabulary of a hostage.

The cashflow read is in Marcus’s column below; short version, the highest-ranked name on this week’s board is an oil and gas producer, and the Cash Flow Memo ranked it before the deal that changes it.

What changes the read is whether this contract is a species or a specimen. The forward calendar tests it immediately. Occidental reports Wednesday, ConocoPhillips and Cheniere on Thursday.⁵ Cheniere is the cleanest tell, because long-dated contracted offtake against a spot-priced sector is the entire LNG business model and the market has never paid it for the duration. The test on those calls is whether any management team names a data center or hyperscaler counterparty, or whether power demand stays in the abstract-tailwind register it has occupied for two years. Thesis breaks if the Chevron deal stays a one-off through the fourth quarter. One contract is an anecdote. Four is a repricing.

Wall Street’s consensus on energy: a terminal-decline sector, correctly priced for no growth. The largest incremental buyer of American electricity just signed up through 2046.

The Tape — W2631

Universe of 94 cashflow-memo names, snap dates 2026-07-26 → 2026-07-31. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

The top of this week’s board is ranking a balance sheet that no longer applies. Magnolia takes the number one composite at 13.0x EV/FCF and a 7.7% FCF yield, both computed off the Q1 10-Q, before the company agreed to buy WildFire Energy for $4.06B and priced a stock offering to help fund it. So the row is accurate and it is stale — a producer that pays for an acquisition partly in equity moves its share count, its debt, and its per-share cash flow in the same week the screen ranked it. Consensus is treating the offering as the news; the offering is the financing. The test is the August 5 print: whether management sizes the combined capex program for 2027, or defers it to the close.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

89 of 92 ranked-eligible names ranked. 3 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-07-31.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

Who’s Getting Paid

Microsoft got paid for spending. Meta got billed for it. Same week, same build.

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 14 minutes. No filler.

Download the memo at telltales.us. Mike, Jason, and Hunt are back Wednesday on episode E2632.

Chapter markers

* Time | Segment

* 0:00 | Opening disclaimer

* 0:15 | Cold open — cash flow did the grading

* 0:45 | Theme — who’s getting paid: Microsoft, Meta, Apple

* 4:45 | Deep dive — page fifteen: Vertex and Lantheus

* 8:45 | Rapid fire — ASML, Intel, Chevron, and the forward week

* 11:45 | Close — Consensus Watch

* 12:45 | Closing disclaimer

Full transcript

Opening disclaimer

Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.

Cold open

Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.

Marcus: And I’m Marcus Graham — the cashflow desk.

Ava: Quick note before we start: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.

Ava: This was the week the AI build stopped being a guide and started being a cash flow statement. Three of the largest companies on earth reported inside 72 hours, and the market handed out three completely different grades for what looks, from the outside, like the same behavior. On Wednesday’s show, episode 2631, Hunt, Jason, and Mike spent their time on open weights versus closed labs, and where the value goes once model economics commoditize[^ep-e2631]. This week the market answered a much narrower version of that question, with money. Cash flow did the grading.

Theme — Who’s getting paid

Ava: Microsoft just got a standing ovation for spending money. Azure crossed $100 billion of revenue in a single fiscal year for the first time[^news-msft-azure-20260730]. Fourth-quarter earnings, $4.74 adjusted, up 23%[^news-msft-q4eps-20260729]. The stock jumped 15% on it[^news-msft-stock-20260730]. And buried underneath the applause: Microsoft Cloud gross margin fell to 68%, and the company’s own explanation was the cost of scaling AI infrastructure and the growing usage of AI features[^news-msft-cloud-margin-20260724]. So the build is already in the margin line. On page 1 of the memo, Apple and Microsoft printed inside two days of each other, and only one of them got that reception. Marcus — who actually got paid this week?

Marcus: Microsoft got paid on the income statement and billed on the cash flow statement, and the market only graded the first one. Going into this print the memo had them at about 38x trailing free cash flow[^memo-msft-evfcf-20260331], on roughly $76 billion of trailing free cash flow that was down about 21% year over year[^memo-msft-fcf-20260331]. That’s Q3 10-Q confirmed; we re-anchor when the 10-K files. Azure crossing that line is real money. So is the cash disappearing into the build. What I’d watch on the next print is whether the revenue line starts catching the capex line, or whether we’re still calling this a growth story two years from now.

Ava: Meta spent the same kind of money and got the opposite grade. Revenue over $60 billion, up 28%[^news-meta-rev-20260730]. Second-quarter free cash flow down 91%[^news-meta-fcf-20260731]. The stock fell 8%, extending a record losing streak[^news-meta-stock-20260731]. And on the call, Mark Zuckerberg said Meta is, quote, getting a lot of offers for compute at a significant premium over what the company paid[^news-meta-compute-20260731]. Free cash flow down 91%, and the pitch is that people would like to rent his GPUs. There was also a $2.4 billion charge for legal proceedings[^news-meta-legal-20260730], and a $14 billion data center venture with BlackRock[^news-meta-blackrock-20260728]. Marcus, what did that $14 billion buy?

Marcus: It bought the ability to keep building without the whole bill landing on Meta’s own cash flow statement. That is what a joint venture is for. Going into this print the memo had Meta at about 30x trailing free cash flow[^memo-meta-evfcf-20260331], on about $50 billion of trailing free cash flow that was still growing 22%[^memo-meta-fcf-20260331]. Q1 10-Q confirmed; we re-anchor when the Q2 10-Q files. So the trailing picture going in was fine. The quarter is what broke. And the move in the stock says the market has decided the quarter is the new trend rather than the exception. I’d weight that as more likely right than wrong, but it is one quarter, and I’d hold that view loosely until the next one confirms it.

Ava: Which brings us to the control group. Apple didn’t build anything, and got marked down anyway. The June-quarter print beat, with net sales around $109 billion and iPhone sales up 22% year over year[^news-aapl-q3-20260731]. It was Tim Cook’s last earnings call as CEO, with the stock at a record[^news-aapl-cookcall-20260729]. He hands the job to John Ternus on September 1 and becomes executive chairman[^news-aapl-ceo-20260729]. And then Apple guided the September quarter to 9–11% revenue growth, below where the Street was, and blamed supply constraints[^news-aapl-guide-20260731]. Goldman Sachs cut its price target to $360 on the guide[^news-aapl-ptcut-20260731]. Morgan Stanley also moved to $360, working off calendar 2027 earnings of $10.30 a share[^news-aapl-mspt-20260731]. Two houses, two different models, the same number. Marcus, this one’s for you.

Marcus: Apple is the counterexample that makes the rest of the week legible. Going into this print the memo had Apple at about 37x trailing free cash flow[^memo-aapl-evfcf-20260328], on trailing capex of roughly $11 billion[^memo-aapl-capex-20260328], which is a fraction of hyperscaler scale, with free cash flow growing 28%[^memo-aapl-fcf-20260328]. FQ2 10-Q confirmed; we re-anchor when the FQ3 10-Q files. So here is the week in one line. The market paid for the build where the revenue already showed up, billed it where it hasn’t, and then marked Apple down for something else entirely. Parts it can’t get. That’s a supply problem, not a valuation problem, and supply problems resolve on a different clock.

Ava: Three companies, one build, three verdicts.

Deep dive — Page fifteen

Ava: Two pharmaceutical deals landed this week, both on page 15 of the memo, and they are the same argument as the hyperscalers — just at a deal table instead of an earnings call. One company had the cash flow to write the biggest check in its history. The other one has cash flow good enough that somebody wants to buy it, and not enough scale to make that go away.

Ava: Vertex agreed to acquire Crinetics Pharmaceuticals for $10 billion in cash, $85 a share — the largest acquisition Vertex has ever made[^news-vrtx-crinetics-20260728]. It also signed a collaboration with AbCellera on next-generation T-cell engagers, $28 million up front[^news-vrtx-abcellera-20260729]. And Vertex reports Monday[^earn-vrtx]. Meanwhile, Curium is in advanced talks to acquire Lantheus for about $7 billion, a deal that could be announced within days[^news-lnth-curium-20260727]. And two days after that report landed, B. Riley raised its price target on Lantheus, to $129 from $97[^news-lnth-briley-20260729]. Marcus — which side of that table would you rather be on?

Marcus: Lantheus is the more interesting one, because the sell side responded to a takeover report by marking the company up. That does not usually happen when the bid is generous. The memo has Lantheus at about 17x trailing free cash flow[^memo-lnth-evfcf-20260331], at roughly a 6% free cash flow yield[^memo-lnth-fcfyield-20260331], with effectively no net debt[^memo-lnth-debt-20260331]. Q1 10-Q confirmed. A debt-free radiopharmaceutical business throwing off that kind of yield is not a distressed seller. What I’d watch over the next two weeks is whether the board treats that number as a floor or a ceiling, and whether a second name shows up before anything gets signed.

Ava: An offer the analysts think is too low. Imagine that.

Marcus: Vertex is on the other side of that trade because its cash flow bought it the option to be. The memo has Vertex at about 30x trailing free cash flow[^memo-vrtx-evfcf-20260331], on about $3.7 billion of trailing free cash flow, up roughly 66% year over year[^memo-vrtx-fcf-20260331]. Q1 10-Q confirmed. That is what lets you write an all-cash check of that size without asking anyone’s permission. The honest caveat is that writing the check is the easy part. This is the largest deal Vertex has ever done[^news-vrtx-crinetics-20260728], which means the integration is unproven, and in the meantime the existing franchise is funding all of it. Monday’s print won’t tell you anything about the acquisition. It’ll tell you whether the base business is still carrying the load.

Ava: And look at what Vertex is assembling on top of the acquisition. That AbCellera collaboration is aimed at multispecific T-cell engagers for autoimmune disease and other conditions[^news-vrtx-abcellera-20260729]. So inside one week: a $10 billion company purchase and a $28 million science partnership. Very different price tags, same instinct. Lantheus, on the other side of the table, is a radiopharmaceutical business[^news-lnth-curium-20260727] — targeted drugs, narrow patient populations, and specialty sales forces that are expensive to build and hard to replace once you have one.

Marcus: Which is why the buy-versus-build math has gone so lopsided. Building a specialty commercial organization takes years you do not get back, so a company with real free cash flow buys one instead, and the price of that shortcut gets set by whoever else has cash that week. Vertex had it. Curium apparently has it. Lantheus is the one being priced. Same mechanism we just watched in the hyperscalers. The currency is a sales force instead of a data center.

Marcus: Same page, same week, and what decided which side of the table each one sat on was how much cash each business throws off. What I’d watch from here is that Lantheus number. If $7 billion moves, it tells you the cash flow was worth more than the bid assumed.

Ava: Two companies, one page of the memo. The cash flow statement wrote the outcome for both.

Rapid fire

Ava: Rapid fire. Three names, then the forward week.

Ava: The most important company in the AI build had one of its worst weeks of the year, and it didn’t report anything. A Shanghai-based, state-backed Chinese company has begun mass producing deep-ultraviolet immersion lithography equipment — the machines ASML has effectively had to itself — reportedly after absorbing staff from a Huawei-backed startup[^news-asml-china-20260729]. The shares slid to their lowest level since early June[^news-asml-stock-20260728]. Bank of America says investors are overreacting to the China threat[^news-asml-bofa-20260728]. Maybe. ASML also posted €5.6 billion of net bookings in mid-2026, on strong demand for its High-NA EUV systems[^news-asml-bookings-20260730]. So the order book is fine and the moat is the open question. Those are different problems, on very different timelines.

Ava: Intel, also on page 3, posted its fastest revenue growth in 15 years and announced 24,000 job cuts inside the same ten days. Second-quarter revenue up 25% to $16.1 billion, the strongest growth since Q3 2011[^news-intc-q2-20260723]. The forward guide topped estimates on data center strength[^news-intc-guide-20260723]. Intel also committed to mass production of its 14A node in 2028[^news-intc-14a-20260724]. And CEO Justin Hotard is cutting 24,000 jobs as part of a restructuring[^news-intc-layoffs-20260728]. Growth and a restructuring in the same breath usually means the growth isn’t coming from where the headcount is.

Ava: And the AI build showed up in an oil major’s earnings. Chevron reported second-quarter earnings of $12.1 billion, $6.11 a share diluted, up 384% from a year ago[^news-cvx-q2-20260731]. Chevron also signed a 20-year power purchase agreement with Microsoft, supplying 2.67 gigawatts of behind-the-meter power to a West Texas data center[^news-cvx-msft-20260731]. Twenty years. Behind the meter. That is a hyperscaler deciding it would rather buy the gas than wait on the grid. And CEO Eimear Bonner said she expects fuel-making margins to stay high for as long as energy markets remain, quote, under stress[^news-cvx-margins-20260731]. Chevron also confirmed the Caspian Pipeline Consortium is flowing again with ships loading this week[^news-cvx-caspian-20260731], and signed preliminary agreements to advance discussions on Iraq’s West Qurna 2 and Nassiriya fields[^news-cvx-iraq-20260731]. A quadrupled quarter, a 20-year utility contract, and two new frontiers, all in one press cycle.

Ava: The forward week is heavy. Palantir and Vertex report Monday[^earn-pltr]. AMD, Caterpillar, Pfizer, Spotify, and TransDigm on Tuesday[^earn-amd]. Wednesday brings Disney, Eli Lilly, Uber, Occidental, and Magnolia[^earn-dis] — which just agreed to buy WildFire Energy for about $4 billion[^news-mgy-wildfire-20260730] and priced a $1.1 billion stock offering the same week[^news-mgy-offering-20260730]. And Thursday: ConocoPhillips, Cheniere, Airbnb, and Lantheus, which may or may not still be an independent company by the time it reports[^earn-lnth].

Close

Ava: That’s the show. Wall Street’s consensus on the AI trade this week: Microsoft’s spending is disciplined and Meta’s is reckless. Same build, same bill. The only real difference is that one of them can already show you the invoice it sent. Cash flow did the grading this week. Microsoft got paid for the spending, Meta got billed for it, Apple got marked down for parts it couldn’t get — and over on page 15, the company with the cash flow wrote the check while the company with less of it got an offer. Next week the forward calendar does the talking. Download the Cash Flow Memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2632. I’m Ava Cabot. Have a good weekend.

Closing disclaimer

Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.

Sources

* AppleInsider. (2026, July 31). Goldman Sachs drops Apple price target, sees growth in 2027. AppleInsider. https://appleinsider.com/articles/26/07/31/unimpressed-goldman-sachs-trims-aapl-target-by-10-after-earnings-call

* AppleInsider. (2026, July 31). Services slowdown pushes Apple’s price target down to $360. AppleInsider. https://appleinsider.com/articles/26/07/31/services-slowdown-pushes-morgan-stanleys-aapl-target-down-to-360

* AppleMagazine. (2026, July 29). Apple CEO transition gets a public preview. AppleMagazine. https://applemagazine.com/apple-ceo-transition-tim-cook-john-ternus/

* Bloomberg. (2026, July 23). Intel earnings: (INTC) forecast tops estimates, fueled by data center growth. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-23/intel-forecast-shatters-estimates-fueled-by-data-center-growth

* Bloomberg. (2026, July 27). ASML shares drop after report of China producing DUV chipmaking tools. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-27/asml-slides-after-report-of-china-beginning-duv-tool-production

* Bloomberg. (2026, July 27). Curium is said to near about $7 billion acquisition of Lantheus. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-27/curium-is-said-to-near-about-7-billion-acquisition-of-lantheus

* Bloomberg. (2026, July 31). Chevron says big fuel margins to persist amid energy stress. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-31/chevron-says-big-fuel-margins-to-persist-amid-energy-stress

* BioPharma Dive. (2026, July 29). AbCellera, Vertex partner on next-gen T-cell engagers. BioPharma Dive. https://www.biopharmadive.com/news/abcellera-vertex-partnership-next-gen-t-cell-engagers/826471/

* Chevron Corporation. (2026, July 31). Chevron reports second quarter 2026 results [Press release]. https://chevroncorp.gcs-web.com/news-releases/news-release-details/chevron-reports-second-quarter-2026-results

* CNBC. (2026, July 24). Intel (INTC) earnings report Q2 2026. CNBC. https://www.cnbc.com/2026/07/23/intel-intc-earnings-report-q2-2026.html

* CNBC. (2026, July 28). ASML Holding NV — Stock price, quote and news. CNBC. https://www.cnbc.com/quotes/ASML

* CNBC. (2026, July 28). Meta partners with BlackRock: Here’s what you need to know [Video]. CNBC. https://www.cnbc.com/video/2026/07/28/meta-partners-with-blackrock.html

* CNBC. (2026, July 29). Tim Cook’s last earnings call comes at momentous time for Apple with stock at record. CNBC. https://www.cnbc.com/2026/07/29/tim-cooks-last-earnings-call-comes-at-momentous-time-for-apple-.html

* CNBC. (2026, July 30). Apple (AAPL) Q3 2026 earnings report: Live updates. CNBC. https://www.cnbc.com/2026/07/30/apple-earnings-live-updates.html

* CNBC. (2026, July 31). Alphabet, Amazon and Microsoft added nearly $1.5 trillion in combined value this week. CNBC. https://www.cnbc.com/2026/07/31/apple-aapl-amazon-amzn-stock-today.html

* CNBC. (2026, July 31). Meta sinks 8%, continuing record losing streak, while Microsoft jumps 15% as AI trade splits. CNBC. https://www.cnbc.com/2026/07/30/microsoft-msft-meta-stock-today-earnings.html

* Fortune. (2026, July 31). Meta earnings reveal cash flow drops 91% — while Zuckerberg writes op-eds about superintelligence. Fortune. https://fortune.com/2026/07/30/zuckerberg-superintelligence-meta-cash-flow-drop/

* Intellizence. (2026, July 28). Companies that announced major layoffs and hiring freezes. Intellizence. https://intellizence.com/insights/layoff-downsizing/major-companies-that-announced-mass-layoffs/

* Investing.com. (2026, July 28). Vertex to acquire Crinetics Pharmaceuticals in $10 billion all-cash merger. Investing.com. https://www.investing.com/news/analyst-ratings/ubs-downgrades-crinetics-stock-rating-on-vertex-acquisition-93CH-4815601

* Investing.com. (2026, July 31). Chevron says Caspian Pipeline Consortium is flowing, ships loading. Investing.com. https://www.investing.com/news/stock-market-news/chevron-says-caspian-pipeline-consortium-is-flowing-ships-loading-93CH-4829114

* Latham & Watkins. (2026, July 30). Latham advises financing sources in connection with US$4.06 billion acquisition of WildFire Energy by Magnolia Oil & Gas. Latham & Watkins. https://www.lw.com/en/news/2026/07/latham-advises-financing-sources-in-connection-with-acquisition-of-wildfire-energy-by-magnolia

* Latham & Watkins. (2026, July 30). Latham advises on US$1.1 billion public offering of common stock by Magnolia Oil & Gas. Latham & Watkins. https://www.lw.com/en/news/2026/07/latham-advises-on-public-offering-of-common-stock-by-magnolia-oil-gas

* MarketScreener. (2026, July 29). B. Riley raises price target on Lantheus Holdings to $129 from $97, keeps Buy rating. MarketScreener. https://www.marketscreener.com/news/b-riley-raises-price-target-on-lantheus-holdings-to-129-from-97-keeps-buy-rating-ce7f51d3d98ffe22

* Microsoft Corporation. (2026, July 24). FY26 Q1 — Performance. Microsoft Investor Relations. https://www.microsoft.com/en-us/investor/earnings/fy-2026-q1/performance

* Microsoft Corporation. (2026, July 29). Microsoft fiscal year 2026 fourth quarter earnings conference call. Microsoft Investor Relations. https://www.microsoft.com/en-us/investor/events/fy-2026/earnings-fy-2026-q4

* Seoul Economic Daily. (2026, July 29). ASML shares tumble 7% on report of Chinese DUV lithography development. Seoul Economic Daily. https://en.sedaily.com/international/2026/07/29/impregnable-asml-rocked-as-china-lithography-report-wipes

* The New York Times. (2026, July 30). Microsoft increases spending on A.I. as profit jumps 31%. The New York Times. https://www.nytimes.com/2026/07/29/technology/microsoft-quarterly-earnings-report.html

* Tom’s Hardware. (2026, July 24). Intel commits to 14A mass production in 2028 as its sales rise 25% year-over-year. Tom’s Hardware. https://www.tomshardware.com/pc-components/cpus/intel-commits-to-14a-mass-production-in-2028-as-its-sales-rise-25-percent-year-over-year

* Unbox Future. (2026, July 30). Inside the 2026 semiconductor surge: Why Lam Research, Micron & AMD rallied on AI chip CapEx. Unbox Future. https://www.unboxfuture.com/2026/07/inside-2026-semiconductor-surge-why-lam.html

* Upstream. (2026, July 31). Chevron sees significant potential in Iraq after latest agreements. Upstream. https://www.upstreamonline.com/field-development/chevron-sees-significant-potential-in-iraq-after-latest-agreements/2-1-2023717

* Variety. (2026, July 30). Meta takes $2.4 billion charge for legal proceedings in Q2, revenue booms 28% to over $60 billion. Variety. https://variety.com/2026/digital/news/meta-q2-2026-earnings-results-legal-proceedings-charge-1236823577/

Internal data

Internal data is provided on a best efforts basis.

Earnings slate

Forward earnings dates and consensus figures are drawn from the episode’s earnings slate, pulled 2026-07-31. See 04. Publishing/shows/weekend-update/W2631/dryrun/earnings_slate.md.

* Palantir, Vertex Pharmaceuticals — 2026-08-03 (Monday)

* Advanced Micro Devices, Caterpillar, Pfizer, Spotify, TransDigm — 2026-08-04 (Tuesday)

* Disney, Eli Lilly, Uber, Occidental Petroleum, Magnolia Oil & Gas — 2026-08-05 (Wednesday)

* Airbnb, Cheniere Energy, ConocoPhillips, Lantheus — 2026-08-06 (Thursday)

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Mike, and Jason walk the Cash Flow Memo for value in a still-expensive market — with Iran re-heating the oil tape, open-weights politics reshaping who captures AI rents, and a full-page scan of who benefits from cheaper tokens.

The Cashflow Memo

Key Takeaways

* Iran–US flare-up leaves Hunt more uncertain than any week since February, but base case stays oil in the $80–90 band (not $120–150); US pullback looks like the only workable option versus ground troops or deeper infrastructure strikes.

* Open-weights models favor hyperscalers (Amazon, Alphabet, Microsoft, Meta, SpaceX) that already sunk CapEx in chips and avoid model-margin rent; Anthropic/OpenAI lobbying for restricted access is the opposite trade.

* Apple’s low CapEx and cash buy optionality, but Siri still needs a real model (open weights or Gemini) and the stock is hardware-defended; hosts note NVIDIA GPU purchases for Gemini after long Nvidia–Apple bad blood.

* Value hunt across the memo: most businesses get AI as a sustaining productivity boost; Uber is the standout disruption risk (Tesla/Waymo autonomy); oil E&P trade early-teens EV/FCF vs a normal 8–10x; midstream 6–8% yields with ~3–4% dividend growth are bond-like (~11%) vs the 15% double-in-five hurdle.

* Next week teed up: AI impact on healthcare (page 19 skipped) plus where value sits in Tesla and SpaceX after large drawdowns; Starlink V3 and robotaxi-as-base-station ideas pressure cable/wireless ROIC.

Show Notes

[00:00] Intro & Cash Flow Memo Download the memo at telltales.us; 30 minutes on energy, technology, and healthcare cash flows.

[00:00:20] Exhibits A–C: Iran, Gas, Deficit Iran–US ceasefire frays; Hunt sees pullback as the only workable path and keeps oil in an $80–90 investment band with more uncertainty than since February. Permian oil growth is pressuring 2027 gas futures under ~$3.50. Deficit path still points at healthcare as the only real spending lever.

[00:06:17] Open Weights vs Closed Labs Hyperscalers align against restricting open-weight models (no model margin to pay); Anthropic/OpenAI lobbied for gatekeeping. Apple’s low CapEx looks fine on hardware cash, but Siri still needs a model — and NVIDIA GPUs for Gemini show the hardware path.

[00:11:25] Memo Hunt: Compute Beneficiaries Uber/DoorDash/Airbnb/Five Below — most get sustaining AI productivity; Uber faces autonomy disruption from Tesla and Waymo. Industrials (copper, lithium, fertilizer) and logistics IT departments stand to gain; copper in racks may stay relevant longer as optical interconnects lag.

[00:16:43] Financials, Energy & Retail Multiples Banks as capital-light cash generators once regulatory risk is met; oil E&P early-teens EV/FCF vs normal 8–10x after the war bid; midstream yields as bond substitutes short of a 15% hurdle. Costco’s scale-economies-shared model at ~50× FCF; Walmart Labs already deep in AI merchandising; PayPal framed as a change-management opportunity.

[00:26:33] Cable, Wireless & Next Week Charter/Comcast trade like telcos as Starlink V3 and space-based capacity raise competition; Elon’s robotaxi-as-base-station idea. Coming attractions: AI in healthcare, plus Tesla and SpaceX valuation levels after drawdowns.

Subscribe for the weekly Cash Flow Memo walkthrough — download the memo at telltales.us and join us next Wednesday.

Cashtags

$AAPL $ABNB $ALB $AM $AMZN $CELH $CHTR $CMCSA $COP $COST $CVX $DASH $DE $EQT $ET $FAST $FDX $FIVE $GNRC $GOOGL $GS $HD $IINN $JPM $KMX $LEN $LNG $LOW $META $MS $MSFT $NEE $NKE $NVDA $PYPL $T $TGT $TMUS $TSLA $SPCX $UBER $UPS $VZ $WMT $XOM

This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →

GE Vernova Is Already Selling 2031. The Scarcity Was Manufactured Twenty Years Ago.

Every company in this week’s news was selling capacity it still has to build. GE Vernova was selling a place in line. It shipped three gigawatts of turbines in the second quarter and booked twenty gigawatts of orders and slot reservations against them.¹ Six or seven claims on the factory for every machine that walked out of it. That is a queue, and Vernova now sets the price of standing in it.

Start with what a slot reservation actually is, because the phrase does a great deal of work inside that backlog number. It is not an order for a turbine. It is a paid claim on a window of factory time, booked years before the machine gets built, before the plant is permitted, before the interconnection queue clears. The customer buys optionality on Vernova’s throughput; Vernova sells scarcity forward. Reservations are running four to five years out, per Utility Dive’s account of Tuesday’s call. Bookings for 2031 delivery are being taken right now, and Scott Strazik expects to be more than halfway contracted for that year by December.²

Which is why the cash showed up early, and why the way it showed up matters more than the amount. Vernova raised its full-year free cash flow guidance to between eleven and a half and twelve and a half billion dollars, up from six and a half to seven and a half.³ It raised the revenue guide by about a billion. A five-billion-dollar cash raise on a one-billion-dollar revenue raise is not operating leverage, and the company says so plainly: the quarter’s free cash flow rose primarily due to higher positive benefits from working capital.⁴ Translation, in the least mysterious sense: a sold-out factory collects customer money long before it collects revenue. In the Cash Flow Memo, Vernova’s line went from thirty-eight times trailing free cash flow in March to twenty-one in June without the share price doing the work.⁵ The denominator moved.

Now the part that decides whether this is a good business or just a good year. Vernova can charge for a place in line because roughly three companies on earth can forge heavy-duty iron at this scale, and the reason there are three is 2002. The 1998-to-2001 merchant power boom pulled forward a decade of gas turbine orders; when gas prices climbed, the orders vanished, the factories emptied, and the downturn consolidated global manufacturing capability into the three suppliers that survived it, per Bloomberg’s reporting on the current bottleneck.⁶ All three remember. Tony Brough, whose firm advises the OEMs, put it flatly last summer: they are expanding, but each of them have been through boom times before so they are taking a measured and careful approach to capacity additions.⁷ That sentence is the investment case. The discipline is not a strategy anyone chose. It is scar tissue, and it converts a cyclical equipment order into a priced option on time.

The other half of the asset is the installed base. Of the hundred seventy-six billion dollars of performance obligations on the June balance sheet, roughly half is services rather than equipment.⁸ That is an annuity on machines already spinning, indifferent to whether the next gigawatt gets financed. The cashflow read is in Marcus’s column below; short version, a free cash flow yield can be manufactured, and this week one of the memo’s cheapest-looking names manufactured its own.

What changes the read is Vernova. Strazik committed on Wednesday to twenty gigawatts of annual output in the third quarter, twenty-four gigawatts in 2028, and actions to produce 30 GW in 2030.⁹ That is a company being paid to dismantle the exact scarcity that prices its own backlog, run by people who lived through the last time the industry tried it. The tell is not the backlog number, which will keep climbing; management guided to at least a hundred twenty-five gigawatts under contract by year end. The tell is 2032. Strazik described healthy discussions with customers about 2032 bookings and then said he needs more time before we can articulate the timing of contracting in ’32.¹⁰ Healthy discussions, no dates. BNP Paribas read that as possible peak momentum in the gas story, and the jury on the thirty-gigawatt expansion as still out.¹¹ Wind is the standing offset: equipment orders fell forty percent year over year, against a four-hundred-million-dollar segment EBITDA loss carried for the year.¹²

Wall Street’s consensus on GE Vernova: a backlog story, and the backlog is the number to track. The backlog is sold out either way. What prices this company is how quickly it decides to stop being scarce.

The Tape — W2630

Universe of 94 cashflow-memo names, snap dates 2026-07-25 → 2026-07-26. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

Salesforce screens as a cash machine on this table, and the balance sheet under that yield changed character in a single quarter. Per the fiscal Q1 10-Q filed in May, Salesforce raised roughly $24.7B of debt and retired a comparable amount of stock, more than doubling debt/FCF to 2.8x. The 9.7% FCF yield in the row above is a yield on a levered equity stub now, and screens ranking it against unlevered software peers are pricing different risk. I read the recap as management agreeing with the screens, which counts for something. The test on the September 2 print is whether operating cash flow grows into the new interest load, and whether the repurchase pace holds with the debt on the books.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

90 of 92 ranked-eligible names ranked. 2 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-07-26.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

Signed, Not Paid

AI capacity got contracted through 2030, and the only company collecting cash this week was selling turbines.

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 99 companies in the Cash Flow Memo. About 14 minutes. No filler.

Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2631.

Chapter markers

* Time | Segment

* 0:00 | Open

* 0:45 | Theme — Who actually collects

* 4:45 | Deep dive — Page 3: AMD and Intel

* 8:45 | Rapid-fire — the week’s signatures

* 11:45 | Close + Consensus Watch

Full transcript

Opening disclaimer

Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.

Open

Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.

Marcus: And I’m Marcus Graham — the cashflow desk.

Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.

Ava: This was the week the AI build got signed, not paid. In five days: Samsung committed to a chip supply agreement with Broadcom worth more than $200 billion[^news-avgo-samsung-20260725]. Apple committed to years of US-made custom silicon with the same company[^news-avgo-apple-20260723]. AMD wrote an equity check to a customer so that customer could buy AMD’s racks[^news-amd-anthropic-20260722]. And Oracle got its credit rating cut for spending[^news-orcl-sp-20260720]. Almost none of that turns into cash this year. On Wednesday’s show, episode 2630, Hunt, Jason, and Mike walked all 20 pages of the Cash Flow Memo and came at this from the other direction — as the models commoditize, the value moves to the infrastructure[^ep-e2630]. This week the infrastructure sent out its invoices. We’re going to look at who can actually collect.

Theme — Who actually collects

Ava: Broadcom spent this week getting paid by both sides of a fight it isn’t in. Samsung signed a memorandum of understanding worth more than $200 billion — high-bandwidth memory, leading-edge foundry, advanced packaging, running through 2030[^news-avgo-samsung-20260725]. Two days earlier, Apple committed to a multiyear program with Broadcom to design and produce custom silicon and wireless connectivity for US-made chips, per Apple’s own newsroom[^news-avgo-apple-20260723]. Same week. Opposite ends of the supply chain. Marcus — who’s paying for that plumbing?

Marcus: Broadcom doesn’t have to pick a winner in the GPU war. It bills the participants. The memo has it at 52x trailing free cash flow, fiscal Q2 10-Q confirmed[^memo-avgo-evfcf-20260503], on about $36 billion of trailing-twelve free cash flow, up roughly 53% from the prior twelve months[^memo-avgo-fcf-20260503]. That multiple isn’t cheap and it isn’t pretending to be. What it’s asking is that the 2030 end of those contracts is real. The test on the next print is whether the AI semiconductor line keeps compounding once the memory allocation is locked in.

Ava: And here’s the part that doesn’t show up in the headline. When AMD launched its Helios rack this week — we’ll come back to that — SemiAnalysis found each rack needs 12 Broadcom Tomahawk switches, and that roughly 85% of the scale-up links inside it run through Broadcom retimers, 500-plus of them per rack[^news-avgo-tomahawk-20260725]. Broadcom is the only merchant supplier with silicon fast enough to do that job. Marcus, what does that do to the Broadcom case?

Marcus: It means Broadcom gets paid on an AMD share gain and on an AMD share loss. That’s a different kind of asset than a chip company. The risk isn’t demand, it’s concentration — the International Trade Commission opened an investigation this week into Samsung memory products and several customers including Broadcom, on a patent complaint from Netlist[^news-avgo-netlist-20260721]. When your position depends on being the only supplier who can do the thing, patent risk is the thing that ends it. Not the order book.

Ava: And then there’s the company that already collected. GE Vernova generated $5.1 billion of free cash flow in the second quarter alone — more than the whole of 2025, per the company’s release[^news-gev-fcf-20260722]. Orders grew 88% organically. Gas power equipment backlog plus slot reservations went from 100 gigawatts to 116, and management now expects at least 125 by year end[^news-gev-orders-20260722]. Total performance obligations are $176.3 billion as of June 30 — and almost exactly half of that is services, not equipment[^news-gev-rpo-20260722]. And per Talnexis hiring data, Vernova opened 284 new roles in the last seven days against about 2,200 open, top five hiring velocity across everything Talnexis tracks[^tlnx-gev-hiring-20260726]. That’s a backlog turning into payroll.

Marcus: Everybody else this week announced. Vernova collected. The memo has it at 21x trailing free cash flow, Q2 10-Q, filed Wednesday[^memo-gev-evfcf-20260630], on $12.4 billion of trailing-twelve free cash flow[^memo-gev-fcf-20260630]. Net debt against that is about a third of a turn[^memo-gev-debtfcf-20260630]. Broadcom’s multiple is priced off cash that’s contracted. This one is priced off cash that already cleared the bank.

Marcus: The services half of that backlog is the part I’d underline. Equipment backlog is a promise to build something. A services backlog on installed turbines is an annuity on machines already spinning, and it’s the half that doesn’t care whether the next gigawatt gets financed. What would change the take is wind — management is still carrying an EBITDA loss in that segment for the year, and Vineyard Wind sued in April to stop them exiting a supply agreement[^news-gev-wind-20260722]. Vernova is also lining up grid contracts in Venezuela, which is its own category of risk[^news-gev-venezuela-20260722].

Marcus: The gap between those two multiples is most of the week in one number. 52x is priced off a contract book that starts converting toward the end of the decade. 21x is priced off cash in the bank. I’d weight the contract-timing risk higher than the market is right now, and I’d watch the 2027 order book on both names.

Deep dive — Page 3: AMD and Intel

Ava: Two American chip companies had the best week either of them has had in years, and neither one of them got paid for it. Page 3 of the memo, same seven days, completely different reasons the cash isn’t there.

Ava: Advanced Micro Devices is putting up to $5 billion into Anthropic[^news-amd-anthropic-20260722], and Anthropic is deploying up to 2 gigawatts of AMD’s MI450 GPUs inside AMD’s Helios racks[^news-amd-mi450-20260722]. Helios entered full production this week[^news-amd-helios-production-20260724], with Microsoft named as a new customer[^news-amd-helios-20260720] and Cerebras signed as a technical partner[^news-amd-cerebras-20260723]. Intel, on the same page, printed $16.1 billion of second-quarter revenue, up 25% year over year — the strongest growth rate since 2011, and its seventh consecutive quarter beating guidance[^news-intc-revenue-20260723][^news-intc-seven-20260724]. It landed Fortinet as the first named external customer of its foundry[^news-intc-fortinet-20260721]. And it lost $11 billion in the quarter on layoff and restructuring charges[^news-intc-loss-20260723]. Marcus — which one of those is the market getting wrong?

Marcus: AMD just financed its own order book. An equity check into a customer who then buys the racks isn’t a sale, it’s a vendor loan with a purchase order stapled to it. The memo has AMD at 97x trailing free cash flow, Q1 10-Q confirmed[^memo-amd-evfcf-20260328], on $8.7 billion of trailing-twelve free cash flow — a 1% yield[^memo-amd-fcf-20260328]. That’s the price on a company whose largest new deployment is partly funded off its own balance sheet. What I’d watch is whether Helios revenue shows up in the August 4 filing or stays in the press releases[^earn-amd].

Ava: A vendor loan with a purchase order stapled to it. Noted.

Ava: There’s a counterweight, and it landed the same week. SemiAnalysis reported that AMD’s MI455X is the first data-center silicon on 2nm, ahead of everything it competes with — and in the same note, that AMD’s software gating massively regressed, with 90% parity against CUDA slipping from this summer out to October[^news-amd-semianalysis-20260725].

Marcus: That’s the whole AMD question in one sentence, and it isn’t a hardware question. AMD has been ahead on paper before. The reason the 97x multiple is a stretch isn’t the silicon, it’s that a customer can’t run the silicon until the software clears parity, and that date has now moved. Anthropic’s commitment doesn’t accelerate a compiler. I’d weight the odds of Helios revenue landing on the original schedule at about 50/50, and October is the date that settles it.

Marcus: Intel’s problem was never the revenue line. Going into this print the memo had no multiple to quote at all — trailing free cash flow was negative $2 billion at the Q1 10-Q[^memo-intc-fcf-20260328], against $13 billion of trailing capex[^memo-intc-capex-20260328]. That’s a company paying for a fab network out of an income statement that can’t carry it yet. The revenue quarter is real, and it doesn’t touch the denominator. Fortinet matters more than the revenue beat does, because external foundry volume is the only thing that eventually makes that capex line rational.

Ava: So the beat isn’t the story. The customer is.

Ava: And Intel is now looking for help carrying it. The company committed this week to 14A mass production in 2028[^news-intc-14a-20260724], and separately it’s seeking operating partners for the delayed Ohio fab — with SK Hynix exploring a role running the site rather than buying it[^news-intc-ohio-20260722].

Marcus: Both of these are the same trade with different collateral. AMD is spending equity to buy demand it can’t fully serve yet. Intel is spending capex to buy capacity nobody has ordered yet. The one with the customer is carrying 97x. The one with the capacity is carrying negative free cash flow and looking for a partner to help run the building. Neither one converts on this quarter’s numbers, and I’d revisit both on August 4 when AMD reports[^earn-amd].

Ava: Two names, one page, both spending someone else’s money to be in the same business. Neither has been paid yet. Which is the week.

Rapid-fire — the week’s signatures

Ava: Tesla asked to be valued as an industrial AI company in the same quarter its car economics went sideways. Deliveries hit 480,126 vehicles, a quarterly record[^news-tsla-deliveries-20260722]. Revenue was $28.24 billion, up about 26% and ahead of consensus[^news-tsla-revenue-20260722]. Then adjusted earnings per share came in at $0.33 against $0.51 expected, with operating profit down 57% as regulatory credits collapsed[^news-tsla-eps-20260722]. On the second-quarter call, Elon Musk said, quote, this is a massive capex year, end quote, and spent his time on robotics, silicon, and energy rather than on cars[^people-musk-capex-20260722]. Tesla also disclosed it bought an unnamed AI hardware company for $1.95 billion in stock during the quarter[^news-tsla-acquisition-20260724]. On the regulatory side the week split both ways: NHTSA denied a petition seeking a formal defect investigation into the emergency door release on about 180,000 vehicles[^news-tsla-nhtsa-20260724], while the separate probe into Full Self-Driving claims in low-visibility conditions is now at the engineering-analysis stage[^news-tsla-fsd-20260722].

Ava: Celsius beat earnings and set a 52-week low on the same day. Page 16 of the memo, and there are two reasons for that. On the print, $0.41 against $0.29 expected[^news-celh-eps-20260723]. The stock still touched $27.45[^news-celh-low-20260723]. Reason one: core Celsius brand net sales grew 6%, a sharp deceleration from prior growth[^news-celh-core-20260720]. Reason two: England published plans to restrict high-caffeine energy drink sales to under-16s, pending a Parliamentary vote[^news-celh-england-20260724]. Bernstein upgraded into the low with a $44 target[^news-celh-bernstein-20260723]. Six other brokers cut their targets and kept their Buy ratings[^news-celh-brokers-20260724]. Starbucks and Chipotle both report Wednesday off the same page[^earn-sbux][^earn-cmg].

Ava: Oracle had the week that answers the question Hunt, Jason, and Mike asked on episode 2629 — cheap, or value trap. The Pentagon awarded Oracle a 10-year software consolidation contract worth up to $7 billion[^news-orcl-pentagon-20260724]. In the same seven days, S&P cut Oracle’s credit rating over the data-center capex[^news-orcl-sp-20260720], and Oracle sued Wisconsin regulators over a $7 billion collateral demand tied to a single data center near Madison[^news-orcl-wisconsin-20260722]. Trailing-twelve free cash flow at Oracle is negative $19 billion, against $56 billion of trailing capex[^memo-orcl-fcf-20260531][^memo-orcl-capex-20260531]. Both of those sentences are true at the same time. A 10-year government contract is exactly the kind of revenue that supports a credit rating. It arrived the same week a ratings agency decided the spending in front of it mattered more.

Ava: Forward week, and it’s the heaviest of the quarter. Page 1 of the memo prints almost all at once — Microsoft and Meta Wednesday, Apple and Amazon Thursday[^earn-msft][^earn-meta][^earn-aapl][^earn-amzn]. Visa, PayPal and UPS Tuesday[^earn-v][^earn-pypl][^earn-ups]. Palantir Monday the 3rd[^earn-pltr]. And AMD Tuesday the 4th, which is when the Helios question gets its first real answer[^earn-amd].

Close + Consensus Watch

Ava: That’s the show. Wall Street’s consensus on this week’s announcements: demand is now confirmed through 2030. Confirmed demand and collected cash are separated by about four years of capex, and exactly one company in the memo shortened that gap this week. Everything else you heard was a signature. Broadcom signed contracts that convert late in the decade. AMD signed a customer it can’t fully serve until its software catches up. Intel signed one foundry customer and went looking for a partner to help run the building. Vernova banked $5.1 billion in 90 days[^news-gev-fcf-20260722]. Hiring data this week from Talnexis — talnexis.com. Download the Cash Flow Memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2631. The AI build got signed this week. Watch who gets paid.

Closing disclaimer

Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.

Sources

* Advanced Micro Devices. (2026, July 22). AMD and Anthropic announce strategic partnership to deploy up to 2 gigawatts of AMD Instinct MI450 Series GPUs [Press release]. https://ir.amd.com/news-events/press-releases/detail/1292/amd-and-anthropic-announce-strategic-partnership-to-deploy-up-to-2-gigawatts-of-amd-instinct-mi450-series-gpus

* Apple Inc. (2026, July 23). Apple to increase spend with Broadcom to produce billions more U.S. chips [Press release]. https://www.apple.com/newsroom/2026/07/apple-to-increase-spend-with-broadcom-to-produce-billions-more-us-chips/

* Bloomberg. (2026, July 22). GE Vernova is preparing to serve Venezuela’s grid this year. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-22/ge-vernova-is-preparing-to-serve-venezuela-s-grid-this-year

* Bloomberg. (2026, July 25). Samsung inks $200 billion chip supply with Broadcom. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-25/samsung-inks-200-billion-chip-supply-with-broadcom

* Business Insider. (2026, July 22). Elon Musk’s posts about making an espresso in FSD are being scrutinized in a Tesla investigation. Business Insider. https://www.businessinsider.com/elon-musk-post-making-an-espresso-fsd-scrutinized-by-regulators-2026-7

* CNBC. (2026, July 20). AMD launches Helios, its first rack AI system to rival Nvidia, adding Microsoft as newest buyer. CNBC. https://www.cnbc.com/2026/07/20/amd-helios-microsoft-ai-nvidia.html

* CNBC. (2026, July 21). Intel’s foundry lands first named customer under CEO Lip-Bu Tan, as Fortinet signs on for security chips. CNBC. https://www.cnbc.com/2026/07/21/intel-foundry-lands-fortinet-as-first-customer-for-security-chips.html

* CNBC. (2026, July 22). AMD to invest up to $5 billion in Anthropic as part of computing power deal. CNBC. https://www.cnbc.com/2026/07/22/amd-anthropic-ai-chip-investment.html

* CNBC. (2026, July 22). Tesla (TSLA) Q2 2026 earnings report. CNBC. https://www.cnbc.com/2026/07/22/tesla-tsla-q2-2026-earnings-report.html

* CNBC. (2026, July 23). Cerebras stock gains on AMD partnership. CNBC. https://www.cnbc.com/2026/07/23/cerebras-stock-gains-on-amd-partnership.html

* CNBC. (2026, July 24). Oracle signs 10-year software contract with Pentagon worth up to $7 billion. CNBC. https://www.cnbc.com/2026/07/23/oracle-wins-10-year-pentagon-software-contract-worth-up-7-billion.html

* Drive Tesla Canada. (2026, July 24). Tesla AI hardware acquisition officially completed in $1.95 billion deal. Drive Tesla Canada. https://driveteslacanada.ca/news/tesla-ai-hardware-acquisition-complete/

* GE Vernova. (2026, July 22). GE Vernova reports second quarter 2026 financial results and raises 2026 financial guidance [Press release]. https://www.gevernova.com/news/press-releases/ge-vernova-reports-second-quarter-2026-financial-results-raises-2026-financial

* GE Vernova Inc. (2026, July 22). Form 10-Q for the quarterly period ended June 30, 2026 [Quarterly report]. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1996810/000199681026000147/gev-20260630.htm

* IndMoney. (2026, July 24). Intel Q2 2026 earnings: Beat, $11B loss, INTC stock reaction. IndMoney. https://www.indmoney.com/blog/us-stocks/intel-q2-earnings-results-intc-stock-reaction

* Intel Corporation. (2026, July 23). Intel reports second-quarter 2026 financial results [Press release]. https://www.intc.com/news-events/press-releases/detail/1776/intel-reports-second-quarter-2026-financial-results

* Investing.com. (2026, July 23). Celsius Holdings stock hits 52-week low at $27.45. Investing.com. https://www.investing.com/news/company-news/celsius-holdings-stock-hits-52week-low-at-2745-93CH-4809509

* Memeburn. (2026, July 22). Oracle’s data center plans hit a problem money can’t solve. Memeburn. https://memeburn.com/oracles-data-center-plans-hit-a-problem-money-cant-solve/

* Musk, E. R. (2026, July 22). Tesla Q2 2026 financial results and Q&A webcast [Earnings call]. Tesla, Inc. https://www.youtube.com/watch?v=9H5y9Uag8AA

* Reuters. (2026, July 24). US agency rejects petition seeking Tesla door-release defect probe. Reuters. https://reuters.com/legal/litigation/us-auto-safety-regulator-denies-petition-seeking-tesla-door-release-defect-probe-2026-07-24

* Semafor. (2026, July 22). Exclusive: Intel seeks operating partners for Ohio chip fab. Semafor. https://www.semafor.com/article/07/22/2026/intel-seeks-operating-partners-for-ohio-chip-fab

* SemiAnalysis. (2026, July 25). Can AMD break the CUDA moat? AMD advancing. SemiAnalysis. https://newsletter.semianalysis.com/p/can-amd-break-the-cuda-moat-amd-advancing

* Talnexis. (2026, July 26). Hiring intelligence: 7-day role velocity across 135 tracked companies. Talnexis. https://www.talnexis.com/

* Teslarati. (2026, July 22). Tesla (TSLA) Q2 2026 earnings results: Miss on EPS, beat on revenue. Teslarati. https://www.teslarati.com/tesla-tsla-q2-2026-earnings-results/

* The New York Times. (2026, July 23). Intel benefits from a new shift in A.I. spending. The New York Times. https://www.nytimes.com/2026/07/23/technology/intel-quarterly-results.html

* The Stock Observer. (2026, July 23). Celsius (NASDAQ:CELH) sets new 1-year low – What’s next? The Stock Observer. https://www.thestockobserver.com/2026/07/23/celsius-nasdaqcelh-sets-new-1-year-low-whats-next.html

* TIKR. (2026, July 24). Celsius fell to a 2026 low as England moved to restrict energy drinks and six brokers cut targets. TIKR. https://www.tikr.com/blog/celsius-fell-to-a-2026-low-as-england-moved-to-restrict-energy-drinks-and-six-brokers-cut-targets

* Tom’s Hardware. (2026, July 24). Intel commits to 14A mass production in 2028 as its sales rise 25% year-over-year. Tom’s Hardware. https://www.tomshardware.com/pc-components/cpus/intel-commits-to-14a-mass-production-in-2028-as-its-sales-rise-25-percent-year-over-year

* Trefis. (2026, July 20). History has an opinion on this CELH price level. Trefis. https://www.trefis.com/stock/celh/articles-v3/607934/history-has-an-opinion-on-this-celh-price-level/2026-07-20

* Utility Dive. (2026, July 23). GE Vernova gas turbine backlog climbs to 116 GW. Utility Dive. https://www.utilitydive.com/news/ge-vernova-gas-turbine-backlog-climbs-to-116-gw/826039/

* Wisconsin Public Radio. (2026, July 20). Oracle’s credit rating cut amid data center legal battle with Wisconsin regulators. WPR. https://www.wpr.org/news/oracles-credit-rating-cut-data-center-legal-battle-wisconsin-regulators

* Yahoo Finance. (2026, July 21). Is Broadcom (AVGO) still undervalued as Netlist patent claims test sentiment? Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/broadcom-avgo-still-undervalued-netlist-061112166.html

* Yahoo Finance. (2026, July 24). AMD stock gains overnight: Analysts laud chipmaker’s server leadership after strong Helios, customer updates. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/amd-stock-gains-overnight-analysts-laud-chipmakers-server-leadership-after-strong-helios-customer-updates-053622107.html

Internal data

Internal data is provided on a best efforts basis.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Jason, and Mike walk the full 20-page Cash Flow Memo, from a shut shipping channel in the Strait of Hormuz to a tiny ophthalmology compounder, hunting for value in an elevated market.

The Cashflow Memo

Key Takeaways

* Energy desk: the Strait of Hormuz South Channel is effectively closed after Greek tanker owners pulled out following drone and missile strikes (two crew deaths), pushing Brent into the 90s and WTI into the low 80s; the deep backwardation says the market expects an Iran accommodation within days, and Hunt agrees one is likely by the weekend.

* Counterintuitive gas call: despite the data-center power narrative, gas-for-power demand is flat (down in ’25, barely up in ’26), so the ’27 gas strip sits near $3.40; LNG demand is robust, but capacity value is accruing to independent power producers (Constellation, Vistra, NRG), none of which are in the memo.

* Fiscal tripwire: defense is asking for ~$1.5T and the total deficit needs to hold near $1.5T or lower to avoid a capital-markets event (a failed Treasury auction) through ’26 and ’27; with interest at ~$1.15T and Social Security off-limits, Medicare and Medicaid (~$1.8T combined) are the only real lever.

* AI value migration: with open-source models (Kimi K3 and others) reaching rough parity, model economics commoditize and value accrues to infrastructure, which is why Amazon and Alphabet are the preferred AI-infra owners; on semis, TSMC’s ~$265B Arizona commitment (we don’t want to leave any food on the table) cements leading-edge pricing power, and the standing risk is under-capacity inviting an industry-funded replacement rather than pricing pressure.

* Healthcare value hunt: Jason prefers BioNTech over Moderna (more disciplined COVID-era spend, longer research runway) and Regeneron over Lilly (repriced for a post-blockbuster future, pipeline at a discount while Lilly rides the weight-loss hype); the team owns Vertex and Harrow, the latter compounding an ophthalmology sales-force edge by co-branding a topical anesthetic alongside EYLEA biosimilars.

Show Notes

[00:27] Exhibits B & C: Oil, Hormuz, and Backwardation The South Channel is effectively closed after Greek owners abandon it under drone and missile fire, lifting Brent into the 90s and WTI into the low 80s. The deep backwardation signals the market expects an Iran accommodation within days.

[04:44] Exhibit B: Why Natural Gas Is Stuck Gas-for-power demand is flat despite the data-center narrative, pinning the ’27 strip near $3.40. LNG demand is robust, but the seven-day capacity value is accruing to independent power producers outside the memo.

[07:00] Exhibit A: The Deficit and the $1.5T Line Defense is asking for roughly $1.5T, and the total deficit must hold near that level to avoid a failed Treasury auction through ’26 and ’27. With interest at ~$1.15T and Social Security untouchable, Medicare and Medicaid are the only real lever.

[08:54] Page 1: AI Infrastructure, Amazon and Alphabet As open-source models reach parity, model economics commoditize and value shifts to compute. Amazon leads infrastructure-as-a-service, with Alphabet closing the gap on Azure.

[11:42] Chinese Open-Source Models and Security Jason (ex-security) argues a model is just a list of weights, so a Chinese model can run safely in a US data center under the right terms of service. The Fable 5 data-capture change and the Hugging Face hack frame the regulatory-capture debate.

[15:39] Page 3: Nvidia and TSMC TSMC’s ~$265B Arizona buildout and don’t leave food on the table line put Intel and Samsung on notice. TSMC sets the leading-edge pace and commands a wafer premium; Nvidia still isn’t a big multiple.

[19:07] Pages 4-6: Media and Telecom Netflix keeps losing ground while Meta stays interesting. Telecom is destructive competition, T-Mobile carries the least debt and the highest multiple, and Starlink is a real threat.

[22:01] Pages 7-8: Payments and Retail Visa and MasterCard remain great businesses facing a software-style challenge; PayPal and Circle both earn on idle float. Lowe’s and Home Depot are a duopoly, Costco and Walmart look expensive.

[24:00] Page 13: Financials Hunt likes all five names. Interactive Brokers has the widest moat on the lowest cost base, and Moody’s is indispensable given the refinancing wall, though both trade rich.

[26:00] Page 14: Industrials Caterpillar at roughly 40x free cash flow rides the power-equipment and reshoring wave versus Deere near 20x, but swapping isn’t smart. TransDigm and Fastenal round out the compounders.

[28:00] Pages 15-19: Pharma BioNTech is the more disciplined cancer-vaccine bet over Moderna, and the team owns Vertex despite disliking big pharma’s treadmill. Regeneron is the value pick over an expensive, hype-driven Lilly.

[31:33] Page 20: Harrow’s Ophthalmology Playbook Harrow is early in commercializing a cluster of eye drugs, leveraging one sales force to co-brand a topical anesthetic with EYLEA biosimilars. Sub-blockbuster drugs are hard to market, which is exactly Harrow’s edge.

[33:52] Close: Software Next Week Next week is another full 20-page walk with a focus on software as an opportunity. Get the memo at telltales.us and join us in seven days.

Cashtags

$AAPL $ALC $AMZN $BNTX $CAT $CHTR $CMCSA $COST $DE $DISH $FAST $GNRC $GOOGL $GS $HD $HROW $IBKR $INTC $JPM $KMX $LLY $LOW $META $MRNA $MS $MSFT $NFLX $NVDA $PFE $PLTR $PYPL $REGN $SPOT $TDG $TGT $TMUS $TSLA $TSM $UNH $V $VRTX $VZ $WMT

This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →

Wall Street Called PayPal Dead Money for Two Years. This Week, Private Capital Sent a Term Sheet.

Two markets looked at the same cash flows this week and reached opposite verdicts. The public market has spent two years pricing PayPal, Comcast, and half the telecom block as value traps — cheap for a reason, and the reason is they’re dying. Then Stripe and the private-equity firm Advent put fifty-three billion dollars on the table for PayPal at a twenty-eight percent premium, and PayPal’s own board came back and said the number was too low.¹² Only one of those two verdicts arrives with committed financing attached.

The tell isn’t the premium. It’s what the premium is buying.

Start with the balance sheet, because that’s where the buyer started. PayPal carries almost no debt and throws off something close to a sixteen percent free cash flow yield.³ To a public shareholder, that yield is a warning — the market’s way of saying the branded-checkout business is in slow decline and the multiple should stay buried. To a private buyer, the exact same yield is fuel. A clean balance sheet generating that much cash finances its own buyout: you borrow against the cash flow, cover the interest several times over, and fix the growth story out of the public eye on a five-to-seven-year clock instead of a ninety-day one. The public market marks PayPal to next quarter’s narrative. Advent underwrites it to the end of the decade.

You could watch the plumbing for that trade get built in real time. Stripe and Advent lined up roughly fifty billion dollars in committed financing from JPMorgan and Morgan Stanley before the bid was even public, per Bloomberg.⁴ And in the same week, KKR started marketing bonds in Germany backed by PayPal’s buy-now-pay-later loans — the first securitization of its kind in Europe.⁵ That’s a second, entirely separate pool of lenders deciding PayPal’s receivables are money-good. When the assets underneath a company finance this easily, the buyout stops being speculative. The debt to do the deal is already there to be borrowed.

Here’s the part the show didn’t have room for: this is not really a PayPal story. It’s a repricing of the entire boring half of the Cash Flow Memo. The same math that turns PayPal into a buyout candidate is sitting on page six under the telecom block — Comcast at a fifteen percent yield, Verizon at seven, every one of them a low-growth cash machine the public market has left for dead.⁶⁷ This is the take-private-of-the-cash-cow playbook, the one that ran hot in 2006 and 2007 — except this cycle the fuel isn’t syndicated bank loans and high yield, it’s private credit: direct-lending funds and asset-backed securitizations that did not exist at anything like this scale a decade ago. A financing system that large doesn’t just make one deal possible. It makes the list of takeable public cash machines far longer than the public market has priced in.

The cashflow read is in Marcus’s column below; short version, the highest-yielding name in the whole memo is a telecom stock the tape is treating as a warning, not a gift.

What changes the read is a term sheet, not a re-rating — and that’s the whole point. The catalyst for the cheap half of the memo was never going to be the public market waking up and paying more. It’s a buyer showing up and taking the company off the market entirely. On PayPal, the test isn’t the headline bid; it’s whether a second bidder appears before earnings on the twenty-eighth — a bank or a card network deciding it can’t let Stripe own these rails — because that’s what turns a negotiation into an auction.⁸ On telecom, the whole block reports Thursday and Friday next week, and the prints will tell the private buyers how fast the broadband base is actually eroding, which is the one number that decides whether these are melting ice cubes or the next names to get a term sheet.⁹

Wall Street’s consensus on the cheap half of the memo: value traps, cheap for a reason, and the reason is terminal decline. Private capital spent this week agreeing about the cash and disagreeing about the ending. The trap, it turns out, has bidders — and they brought their own financing.

The Tape — W2629

Universe of 94 cashflow-memo names, snap dates 2026-07-10 → 2026-07-17. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

Comcast is the highest-yielding cash machine in the memo, and the tape is treating that yield as a warning, not a gift. Going into Thursday’s print, the memo has Comcast at 6.5x EV/FCF and a 15.3% trailing FCF yield — a multiple that only pencils if the broadband base is melting. But consensus has next-twelve-month revenue down just 1.3%, so the whole read reduces to erosion speed: a base that leaks two or three points a year more than covers you here; one that loses faster to Starlink does not. I read the multiple as a bet on the pace of decline, not the fact of it. The test Thursday is broadband net adds and churn, not headline EPS — the same number the private buyers circling the cheap half of the memo are watching.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

91 of 91 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-07-17.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

The Trap Has Bidders

While the market prices telecom and payments cash machines for the graveyard, the buyers keep writing billion-dollar checks.

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 14 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2630.

Chapter markers

* Time | Segment

* 0:00 | Open

* 0:45 | Theme — Telecom’s Squeeze

* 4:45 | Deep dive — PayPal

* 8:45 | Rapid-fire — the week’s checkbooks

* 11:45 | Close + Consensus Watch

Full transcript

Opening disclaimer

Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.

Cold open

Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.

Marcus: And I’m Marcus Graham — the cashflow desk.

Ava: Quick note before we start: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.

Ava: Here’s the whole week in one sentence. The public market spent five days pricing its own cash machines for the graveyard — single-digit multiples, double-digit yields, telecom and payments left for dead. And the buyers spent the exact same five days writing billion-dollar checks for those companies. Both of those things happened. They can’t both be right. On Wednesday’s show — episode 2629 — Hunt, Jason, and Mike went value-hunting and found it hiding in plain sight on page 1, in the hyperscalers everyone already owns.[^ep-e2629] This weekend we go to the other end of the memo: to the names the market gave up on, and the people who just tried to buy them.

Theme — Telecom’s Squeeze

Ava: Start with the group nobody wants to own. On page 6 of the Cash Flow Memo this week — the entire telecom block: AT&T, Verizon, T-Mobile, Charter, Comcast.[^memo-page6-20260717] And the squeeze on that page is running in two directions at once. From the outside, it’s satellites — Bernstein cut Comcast’s price target to $28 this week, naming SpaceX’s Starlink as a real threat to the cable broadband business.[^cmcsa-bernstein-pt-20260714] Which is the tell, because in the same breath Comcast was quietly still building — wiring up another 1,500 homes in rural Florida, most of them never served before.[^cmcsa-xfinity-expansion-20260713] Marcus — the market’s already pricing these like they’re melting. Is it right?

Marcus: On the cheap ones, I read it as a bet, not a mistake. Comcast’s at 6.5x free cash flow, a 15% yield[^memo-cmcsa-evfcf-20260331][^memo-cmcsa-yield-20260331] — that’s a decline multiple, not a value multiple. So the page comes down to one question: is the decline terminal, or just slow. If the broadband base erodes only 2 or 3% a year, that yield more than covers you. If Starlink takes real share, it doesn’t. The memo can’t settle it — the prints start this week, and they’ll tell us more than the multiple does.

Ava: And the money is not sitting still while it waits. Verizon spent the week shrinking on purpose — selling 274 company-owned stores to six operators and cutting 500 corporate jobs, taking its store count down to 1,000 next month.[^vz-stores-layoffs-20260716] Marcus, Verizon carries the fattest dividend on the page and the heaviest balance sheet behind it.

Marcus: Verizon’s the balance-sheet name. 13x free cash flow, a 7% yield, but 7x debt to free cash flow[^memo-vz-evfcf-20260331][^memo-vz-yield-20260331][^memo-vz-debtfcf-20260331] — near the top of the memo on leverage. At that payout and that debt load, selling stores and cutting jobs is just how they keep the dividend covered while the top line barely moves. It’s defense, not investment. I’d hold that read until the print Friday.

Ava: And then there’s the one going the other way entirely. T-Mobile didn’t shrink the business — it squeezed the customer. This week it force-migrated roughly 8 million people off their old plans onto pricier ones, broke a pile of free-line promotions doing it, and now has until the end of the month to answer the FCC on price-lock complaints.[^tmus-migration-20260713][^tmus-fcc-20260714] Marcus, T-Mobile’s the odd one out on this page.

Marcus: T-Mobile’s the odd one, and it’s priced that way. 16x free cash flow, more than double the cable names, and unlike them its free cash flow is still growing — it bought back $12 billion of its own stock last year.[^memo-tmus-evfcf-20260331][^memo-tmus-buyback-20260331] So the page sorts cleanly: Comcast and Verizon are cheap because nobody believes the growth, and T-Mobile’s expensive because people do. That 8 million-customer migration is what funding the growth looks like from the inside, and whether it holds is a regulatory question now, with the FCC answer due this month.

Ava: One sector, both ends of the squeeze. And every name on that page reports inside the next week, so we will know a lot more by Friday.

Deep dive — PayPal

Ava: Which brings us to the collision at the center of the whole week. PayPal is the cheapest cash machine in the entire memo — and this week somebody tried to buy it, and the board said the price was too low. Wednesday, Stripe and the private-equity firm Advent put a joint offer on the table: $53 billion, $60.50 a share, a 28% premium.[^pypl-stripe-advent-bid-20260715] The stock jumped 16% on the news.[^pypl-stock-surge-20260715] And then, two days later — today — PayPal’s board came back and called the offer inadequate, said it undervalues the company, citing execution and regulatory risk.[^pypl-board-inadequate-20260717] A 28% premium. And the answer was no. Marcus — is the board delusional, or is it doing the math the market won’t?

Marcus: It’s doing the math the market won’t. Going into this, the memo had PayPal at about 6x free cash flow, a 16% yield[^memo-pypl-evfcf-20260331][^memo-pypl-yield-20260331] — the price you pay for a business you think is dying, and PayPal isn’t dying, it’s just boring. And here’s the part the market kept ignoring: last year PayPal bought back more of its own stock than it generated in free cash flow.[^memo-pypl-buyback-20260331] Management’s been telling you it’s cheap with the checkbook for two years. This week a buyer agreed. The board’s read is just that the first bid came in low.

Ava: So the smart-money buyer and the company both think it’s underpriced. It was the public market that had it wrong the whole time.

Marcus: That’s the trade, and you can see why a private buyer wants it. PayPal carries almost no debt — under 2x free cash flow.[^memo-pypl-debtfcf-20260331] A clean balance sheet throwing off a 16% yield is easy to finance: a buyer like Advent borrows against that cash flow, covers the interest several times over, and fixes the growth story out of the public eye. Stripe and Advent already lined up roughly $50 billion in committed financing from JPMorgan and Morgan Stanley.[^pypl-financing-20260715] So funding isn’t the constraint here.

Ava: And you could see the plumbing for that trade getting built in real time this week, couldn’t you?

Marcus: You could. Same week as the bid, KKR started marketing bonds backed by PayPal’s buy-now-pay-later loans in Germany — the first securitization of its kind in Europe.[^pypl-kkr-bnpl-20260715] That’s a second set of lenders deciding PayPal’s receivables are money-good. When the assets underneath a company finance that easily, the buyout math gets a lot less speculative — the debt to do the deal is already there to be borrowed.

Ava: The lenders showed up before the bidders did. Tells you something.

Marcus: It tells you the cash is real, and that the debate now is about price, not about whether the business is worth owning.

Ava: So where does this go from here?

Marcus: I’d weight it. A board calling a 28% premium inadequate is usually the opening move in a negotiation, not the end of one — so the base case, call it 60%, is a raised bid, something with a 7 in front of it. Maybe 25% of the time it falls apart on financing or regulatory risk and PayPal drifts back to its boring multiple. The rest is a real bidding war, if a bank or a card network decides it can’t let Stripe own these rails. What I’d watch isn’t the headline price — it’s whether a second bidder shows up, because that’s what would turn this from a negotiation into an auction.

Ava: An auction for the company Wall Street spent two years calling dead money. And they report earnings the 28th,[^earn-pypl] right into the middle of all of it.

Rapid-fire — the week’s checkbooks

Ava: Which is the theme of the whole rest of the week, because PayPal was not the only check written. A few big ones, and then the forward calendar to close.

Ava: One. The biggest check of the week wasn’t in tech at all. NextEra and Dominion filed to merge — a $67 billion all-stock deal that would create the largest regulated electric utility in the country, around 10 million customer accounts across Florida, Virginia, and the Carolinas.[^nee-dominion-merger-20260715] To buy the regulators’ blessing, they’re dangling $2.25 billion in bill credits for customers in Virginia and the Carolinas — the toll you pay to combine two utilities this big.[^nee-dominion-merger-20260715] Here’s the cashflow footnote, though: NextEra already carries about 16x debt to free cash flow — one of the most levered names in the entire memo.[^memo-nee-debtfcf-20260331] And its answer to that was to go get bigger. Powering the AI build costs real money, and somebody has to borrow to do it. This one closes in 2027, if the regulators sign off.

Ava: Two. The checkbooks were out in pharma, too. Eli Lilly agreed to pay up to $3.8 billion for a company called AtaiBeckley, to get a Phase 3 nasal spray for depression that hasn’t responded to anything else — a psychedelic-derived drug, bought as pipeline insurance.[^lly-ataibeckley-acquisition-20260716] That’s the pattern of the whole week: if you can’t grow it, buy it.

Ava: Three. Now the counter-programming, because while all that cheap cash flow changed hands, the market was busy paying any price for the winners. Apple, page 1 of the memo, reclaimed the title of world’s most valuable company this week — $4.88 trillion, edging back past Nvidia.[^aapl-nvda-20260717] HSBC upgraded it to a Buy the same day and pushed its price target from $260 up to $366 on the AI story.[^aapl-hsbc-20260717] Apple trades around 35x free cash flow.[^memo-aapl-evfcf-20260328] Nobody is calling that a value trap.

Ava: Four. Also on page 1 — Tesla. Best quarter in the company’s history: 480,000 vehicles delivered in the second quarter, up 25%.[^tsla-q2-vehicles-20260715] And it reports Wednesday. Now hold that delivery number up against the memo: Tesla trades at nearly 200x free cash flow — the single most expensive name in the whole universe.[^memo-tsla-evfcf-20260331] Same memo, same week: 200x for Tesla, 6x for PayPal. That spread — right there — is what this entire show is about.

Ava: And five, the forward calendar, because next week is a wall of earnings. Tuesday, Interactive Brokers.[^earn-ibkr] Wednesday is the big one — Alphabet, ServiceNow, and AT&T all report.[^earn-googl][^earn-now][^earn-t] Then the telecom block we opened with closes out the week: Comcast and T-Mobile on Thursday, Verizon and Charter on Friday.[^earn-cmcsa][^earn-tmus][^earn-vz] We’ll have the prints for you next Saturday.

Close

Ava: That’s the show. Here’s the one sentence to take with you: this week the public market priced its cash machines for the graveyard, and the private buyers showed up with checks. Telecom at 6 times, PayPal at 6 times — and a $53 billion bid the board still called too cheap. Somebody is wrong, and we find out who over the next few quarters. Wall Street’s consensus on the old cash machines — telecom, payments, the unglamorous half of the memo — is that they’re value traps: cheap for a reason, and the reason is they’re dying. Then somebody put $53 billion on one of them. Turns out the trap has bidders. So keep one eye on the boring half of the memo this coming week — the telecom prints, the PayPal board, whoever’s next with a checkbook. That’s where the argument gets settled. Everything we covered comes straight out of the Cash Flow Memo — download it at telltales.us. Hunt, Jason, and Mike are back Wednesday, on episode 2630. I’m Ava Cabot. Thanks for listening.

Closing disclaimer

Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.

Sources

* Apple tops Nvidia as world’s largest company amid tech rotation. (2026, July 17). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-17/apple-tops-nvidia-as-world-s-largest-company-amid-tech-rotation

* Apple upgraded to Buy by HSBC on agentic AI, hardware pipeline. (2026, July 17). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-17/apple-upgraded-to-buy-by-hsbc-on-agentic-ai-hardware-pipeline

* Eli Lilly and Company. (2026, July 16). Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions [Press release]. PR Newswire. https://www.prnewswire.com/news-releases/lilly-to-acquire-ataibeckley-to-advance-therapies-for-treatment-resistant-depression-and-other-mental-health-conditions-302827468.html

* FCC demands answers from T-Mobile for violating customer commitments. (2026, July 14). PhoneArena. https://www.phonearena.com/news/t-mobile-plan-migration_id181869

* KKR markets debt backed by PayPal’s buy now, pay later loans. (2026, July 15). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-15/kkr-markets-debt-backed-by-paypal-s-buy-now-pay-later-loans

* NextEra Energy. (2026, July 15). NextEra Energy and Dominion Energy file to combine, building a stronger company to meet growing power demand across four of America’s fastest-growing states [Press release]. NextEra Energy Newsroom. https://newsroom.nexteraenergy.com/2026-07-15-NextEra-Energy-and-Dominion-Energy-file-to-combine,-building-a-stronger-company-to-meet-growing-power-demand-across-four-of-Americas-fastest-growing-states-while-keeping-energy-affordable-and-reliable

* PayPal board sees Stripe-Advent offer as inadequate, sources say. (2026, July 17). Reuters via Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/exclusive-paypal-board-sees-stripe-222532613.html

* PayPal stock soars on report of buyout proposal from Stripe, Advent. (2026, July 15). Yahoo Finance. https://finance.yahoo.com/markets/stocks/article/paypal-stock-soars-on-report-of-buyout-proposal-from-stripe-advent-131101969.html

* PayPal works with Goldman, Evercore as Stripe, Advent make $50B-plus offer. (2026, July 15). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-15/stripe-advent-offer-to-buy-paypal-for-53-billion-reuters-says

* SpaceX’s Starlink threat causes Bernstein to cut Verizon, AT&T, Comcast PTs. (2026, July 14). Invezz. https://invezz.com/news/2026/07/14/spacex-s-starlink-threat-causes-bernstein-to-cut-verizon-att-comcast-pts/

* Stripe, Advent make $53 billion takeover offer for PayPal, sending stock soaring. (2026, July 15). CNBC. https://www.cnbc.com/2026/07/15/stripe-advent-offer-to-buy-paypal-for-more-than-53-billion-reuters.html

* T-Mobile customers, your bill could increase today. (2026, July 13). Droid Life. https://www.droid-life.com/2026/07/13/t-mobile-customers-your-bill-could-increase-today/

* Tesla (TSLA) scores the best 2nd quarter ever, energy business spikes, announces Q2 2026 earnings call schedule. (2026, July 15). Tesla Oracle. https://www.teslaoracle.com/2026/07/15/tesla-tsla-scores-the-best-2nd-quarter-ever-energy-business-spikes-announces-q2-2026-earnings-call-schedule/

* Verizon cuts store workers in reorganization strategy. (2026, July 16). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-16/verizon-cuts-store-workers-in-reorganization-strategy

* Xfinity and Comcast Business high-speed internet now available to more than 1,500 homes and businesses in Flagler Estates. (2026, July 13). Business Wire. https://www.businesswire.com/news/home/20260713993329/en/Xfinity-and-Comcast-Business-High-Speed-Internet-Now-Available-to-More-Than-1500-Homes-and-Businesses-in-Flagler-Estates

Internal data

Internal data is provided on a best efforts basis.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hormuz risk pushes Hunt’s oil call toward $80 (not $90–100), the team hunts for value on a high market — and lands on hyperscaler infrastructure over AI models — while healthcare delivers the first MRD-guided cancer approval and a live UNH margin-recovery setup.

The Cashflow Memo

Key Takeaways

* Hunt on Hormuz: a multi-week/month US–Iran stalemate keeps crude closer to $80 than $65 (not $90–100); producers still budget off the 2027 strip, so higher spot just widens backwardation rather than spurring rig activity.

* Value on page one of the memo: Amazon, Microsoft (~20x earnings), and Google/Alphabet (~30x) look reasonable once hyperscaler CapEx is treated as optional and data-center replacement cost is priced as a real asset; Jason argues models are commoditizing and the durable value is token infrastructure (Amazon Trainium + hosting overlooked).

* Oracle near a 52-week low after the OpenAI capacity commitment and ~$110B net debt looks more value trap than bargain; IBM’s mainframe weakness this week is a signal that legacy IT budgets are being redirected to AI, and the hosts float that canceled OpenAI deals could be equity-accretive if capacity re-contracts on the open market.

* Memory inflation (gigawatt DC cost maybe doubled) is the live constraint on Nvidia: if hyperscaler CapEx does not re-rate another 30–40%, chip budgets get crowded out even if token demand stays strong; TSMC’s $60B CapEx year still screens cheap net of Taiwan political risk.

* Healthcare: first FDA approval of a cancer treatment gated on an MRD (molecular residual disease) blood test (Roche/Genentech, bladder) validates the MRD-supplier thesis; UNH expected to show margin bounce on high-20s/low-30s premium hikes; BioNTech preferred over Moderna on cash discipline; Vertex’s non-opioid pain drug is inflecting as PBM formulary frictions ease; Harrow’s Q1 CVS co-pay buy-down error (negative revenue on formulary patients) is the near-term watch item.

Show Notes

[00:00:00] Intro & Welcome Mike opens Telltales; grab this week’s Cash Flow Memo at telltales.us.

[00:00:26] Exhibits A–C: Deficit, Hormuz & Oil Structure Hunt frames a multi-week Hormuz stalemate as closer-to-$80 crude with wider backwardation, producers still deciding off the 2027 strip; Exhibit A deficit runs roughly flat YoY through May, and any eventual sovereign-credit discipline will hit healthcare first.

[00:04:34] Where Is the Value? Hyperscalers on Page One Mike and Jason make the case for Amazon, Microsoft (~20x), and Google (~30x) as infrastructure bets: CapEx is optional, replacement cost of installed data centers is high, and OpenAI lease stress only reinforces that tokens-and-capacity — not the model layer — is where value accrues. Amazon’s Trainium and hosting playbook get special attention.

[00:08:24] Oracle: Cheap or Value Trap? Near a 52-week low with ~$110B net debt and heavy OpenAI-linked CapEx, Oracle draws a Charter-style leverage caution; IBM’s mainframe weakness is read as AI budget cannibalization of legacy software, and the hosts float that canceled OpenAI deals could re-rate capacity more cleanly.

[00:11:07] Nvidia, TSMC, Micron & the Memory Tax Nvidia and TSMC still screen as cheap on the memo; Jason’s live risk is memory cost doubling the price of a gigawatt of data center, crowding chip orders if hyperscaler CapEx doesn’t re-rate another 30–40%.

[00:12:34] Meta, Netflix & Content Share Meta’s cash-flow machine is hard to own without trusting Zuck’s CapEx (well above maintenance for the ad AI flywheel); Netflix at ~$73 looks like a value trap as market-share fears and content mix (Paramount improving) pressure the stock after walking away from Warner.

[00:15:43] Healthcare: MRD Approval, UNH Margins, Lilly & Cash-Rich Biotechs First FDA approval of a treatment administered off an MRD molecular test (Roche/Genentech, bladder cancer) validates the residual-disease thesis; UNH expected to print a margin bounce on high-20s/low-30s premium hikes; Lilly stays expensive for a reason; BioNTech preferred to Moderna on post-COVID cash discipline.

[00:21:29] Vertex Pipeline & Harrow/CVS Fix Vertex: kidney PDUFA path, non-opioid pain drug prescription data inflecting as PBM formulary issues ease, and a type-1 diabetes stem-cell program advancing; Harrow’s Q1 CVS co-pay buy-down created negative revenue on formulary patients — corrected, but Q2 commentary is the tell.

[00:24:54] Next Week & Close Hunt tees up page-20-and-back value hunting for next week; World Cup final Sunday in New Jersey; back in seven days.

Get the full Cash Flow Memo with updated financials on ~80 companies at telltales.us — new episodes every week.

Cashtags

$AMZN $BNTX $BRK.B $BWA $CHTR $CVS $GOOGL $HROW $HYNX $IROC $JPM $KO $LLY $META $MRNA $MSFT $MU $NFLX $NVDA $ORCL $PFE $PZG $TSM $UBER $UNH $VRTX

This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →

Micron and Intel Poured the Same Concrete This Week. The Market Paid One and Punished the Other.

Micron and Intel spent the same seven days making the same bet: tens of billions of dollars, poured into American fabs, on the promise that the chips coming out the other end will pay for the concrete. The market paid one and punished the other. Micron raised its U.S. commitment to a quarter-trillion dollars and poured first concrete in Clay, New York a full quarter ahead of schedule, and the stock treated it as vindication.¹² Intel spent the week watching its process-node timeline slip toward 2027 and its oldest rival pass it in the one number that was supposed to be safe. Same reshoring headline. Opposite verdict.

The tell isn’t who’s spending. Both are spending. The tell is whose cash already showed up.

Page three of the Cash Flow Memo put both names side by side this week, and the cash flow statements underneath them could not look less alike. Micron’s free cash flow grew almost nine hundred percent year over year, to roughly twenty-six billion dollars trailing, and the stock rose with it — about forty times trailing free cash flow, which is not a stock getting more expensive so much as a company whose cash generation finally caught its own multiple from behind.³ The two-hundred-fifty-billion-dollar pledge and the early concrete are Micron telling you, per Bloomberg, that it reads this as a supercycle and not a spike.⁴ That’s the bull case, and the cash flow statement is genuinely backing it.

Here’s the part the show didn’t have room for. Memory is the most violently cyclical business in semiconductors, and a cash-flow explosion of this size has, in every prior cycle, been the sound a top makes — peak DRAM pricing, printed straight to the cash flow line, right before it reverts. The entire bull thesis is that this time is structurally different: HBM demand from the AI buildout, long-dated contracts, three suppliers finally acting disciplined instead of flooding the market. Grant all of it, and you still owe yourself the honest shape of it. The contracted, AI-tied book is a slice; the merchant DRAM that fills out the rest still rides the spot cycle, and the swing factor that decides which way the whole thing breaks isn’t Micron at all. It’s whether Samsung and SK Hynix hold supply discipline or reach for share. A nine-hundred-percent cash number tells you the cycle is at its best. It does not tell you the cycle is over.

Intel is the same lesson photographed from the other side. There’s no honest multiple to put on it — free cash flow is negative, capex ran about thirteen billion trailing, and none of that spending has turned into a profitable 18A yield yet.⁵ The number that actually moved this week wasn’t a valuation ratio; it was five point eight billion to five point one billion, AMD reported over Intel in data-center revenue, a line that had never crossed before.⁶ Intel is spending upstream of execution it cannot yet prove. Micron is spending downstream of demand it can already bank. The market isn’t anti-capex or pro-capex this week. It’s pricing the timing of the payoff — and it sorted the two names accordingly.

The cashflow read is in Marcus’s column below; short version, the best yield-and-growth combination on the entire tape this week isn’t even a chip name. It’s the copper going into the buildings both of these companies are racing to fill.

What changes the read is a calendar, not an opinion. Taiwan Semi reports Thursday, and it’s the real test of whether Micron’s supercycle extends across the chip complex or stays a memory-only story; ASML reports Wednesday, the upstream tell on whether the orders behind all this concrete are still coming.⁷⁸ On Micron itself, the test on the next print is whether DRAM pricing holds — the thesis breaks the day spot rolls over and the contracted slice can’t carry the merchant book. On Intel, the test isn’t an earnings beat at all. It’s whether 18A yields profitably on the 2027 timeline this week’s reporting just laid out. Mark both.

Wall Street’s consensus on the chip complex: memory and logic are one semiconductor trade. Micron and Intel just spent a week proving they’re two — one compounding, one pricing in a turnaround a year later than it hoped. The harder question is the one the cash explosion buries: whether Micron’s nine hundred percent is a new plateau, or the same old memory peak wearing an AI badge.

The Tape — W2628

Universe of 94 cashflow-memo names, snap dates 2026-07-03 → 2026-07-10. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

The best-balanced name on the tape this week isn’t a chip stock or a software stock — it’s a copper miner. Freeport-McMoRan tops the composite at a 6.7% FCF yield against 20.4% NTM revenue growth, at 14.9x EV/FCF. That pairing — cash-cow yield bolted to growth-stock top line — is the AI power buildout showing up one layer beneath the silicon. Every data center Micron and Intel are racing to feed needs copper by the ton, and the tape is starting to pay the picks-and-shovels before the second-order names catch a bid. Consensus still files Freeport under cyclical commodity, which is the read that misses when a secular demand leg gets bolted onto a cyclical business. The test is the Q2 print later this month: whether realized copper pricing confirms the growth the tape is already paying for.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

91 of 91 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-07-10.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

W2628 — Micron’s Cash Flow Explosion, Intel’s Data-Center Loss, and Satellites Coming for Cable

Micron’s cash flow explosion, Intel’s data-center loss, and satellites coming for cable.

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the companies in the Cash Flow Memo. About 14 minutes. No filler.

Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2629.

Chapter markers

* Time | Segment

* 0:00 | Opening disclaimer

* 0:15 | Cold open — throughline + prior-Wed callback

* 0:50 | Theme — Satellites Come for Cable (Comcast, Charter, T-Mobile)

* 5:00 | Deep dive — Micron vs. Intel

* 9:15 | Rapid-fire (NextEra Energy, Apple, Broadcom)

* 11:45 | Close — Consensus Watch + forward week

* 12:15 | Closing disclaimer

Full transcript

Opening disclaimer

Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.

Cold open

Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.

Marcus: And I’m Marcus Graham — the cashflow desk.

Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.

Ava: Micron just proved what it looks like to win the right side of a technology cycle. Intel proved what it looks like to lose one. Same week, same memo page, completely different cash flow statements — one company’s free cash flow is up almost 900%, the other’s is negative. And it wasn’t just semiconductors — Comcast, Charter, and T-Mobile all got hit with the same question from Wall Street this week: what happens to your subscriber base when a satellite can do what your cable line does? Two banks think it’s a real problem. One thinks it’s overblown. We’ll get into who’s actually right, per the numbers.

Ava: On Wednesday, Hunt, Jason, and Mike ran their mid-year predictions scorecard — grading calls on pharma M&A, the AI buildout, and Tesla’s Robotaxi race against Waymo, closing out the full review without needing a second week[^ep-e2628]. This weekend, two different incumbent stories: who’s getting outflanked, and who’s spending like they know it.

Theme — Satellites Come for Cable

Ava: On page 6 of the Cash Flow Memo this week — Comcast, Charter, and T-Mobile all got the same verdict delivered from three different directions. The threat has a name now: Starlink. It’s been a hypothetical for two years. This week, for the first time, the sell side started putting actual subscriber-loss numbers on it instead of just gesturing at the risk — and the three companies are responding to that same threat in three completely different ways.

Ava: Comcast is dealing with it by spending on two fronts at once. Comcast-owned Sky agreed to buy ITV’s media and entertainment business for up to £1.6 billion — roughly $2.1 billion — with a £200 million earn-out riding on future ad performance[^cmcsa-sky-itv-acquisition-20260706]. Closer to home, Comcast also hit a construction milestone this week, wiring 15,700 new homes and businesses in New Jersey for Xfinity[^cmcsa-phillipsburg-expansion-20260707] — the fiber build going one direction while Wall Street models the satellite bleed going the other. And that’s the real story: Morgan Stanley cut its Comcast price target to $30 from $33 this week, now modeling Starlink at 16 million U.S. broadband subscribers by 2030, costing Comcast and Charter combined 400,000–500,000 broadband subscribers a year[^cmcsa-morgan-stanley-target-20260707]. Marcus — is 6.5 times too cheap, or exactly right?

Marcus: Comcast is the cheapest stock in the entire memo, and the market’s telling you exactly why it’s willing to leave it there. 6.5 times trailing free cash flow, on a 15% yield[^memo-cmcsa-evfcf-20260331]. Free cash flow was already down about 21% year over year going into this[^memo-cmcsa-growth-20260331]. That’s not a value stock. That’s a stock priced for a shrinking subscriber base — and this week Morgan Stanley just told you how much more shrinking they expect. The test is whether the ITV content actually slows the bleed, or whether Morgan Stanley’s subscriber-loss estimate turns out to be the optimistic one.

Ava: Charter’s getting hit even harder — and it’s not just one bank. Barclays slashed its price target from $200 to $130 this week[^chtr-barclays-target-20260708], and Wells Fargo cut theirs too, citing the same deteriorating broadband trend[^chtr-wells-fargo-target-20260707]. Charter also confirmed it’s shutting down a Network Operations Center team this week[^chtr-noc-closure-20260709] — cost-cutting on the ground while two banks cut targets on paper. The one piece of good news: a California regulator recommended approval of Charter’s $34.5 billion acquisition of Cox Communications, clearing a real hurdle toward closing[^chtr-cpuc-recommendation-20260709]. Marcus, the cashflow take.

Marcus: Charter’s the one carrying real balance-sheet risk in this story. 12.5 times trailing free cash flow, but the number that actually matters is leverage — debt to free cash flow at 10.5 times[^memo-chtr-evfcf-20260331][^memo-chtr-debtfcf-20260331]. Free cash flow’s already down 12% year over year[^memo-chtr-growth-20260331]. That kind of price target cut from Barclays in one note isn’t analyst noise — that’s a bank telling you the subscriber math and the leverage math are now the same problem. Watch the leverage ratio, not the multiple. That’s what breaks first if Cox doesn’t close clean or the bleed accelerates.

Ava: And then there’s T-Mobile — the one name in this trio Wall Street can’t agree on. Bank of America upgraded T-Mobile to Buy this week, $220 price target, arguing the market is straight-up overreacting to satellite fears[^tmus-bofa-upgrade-20260706]. Two days later, Wells Fargo initiated coverage at Equal Weight, $170 target, citing Starlink as a real threat to postpaid growth[^tmus-wf-initiation-20260708]. It wasn’t a clean week operationally either — a network outage on July 7 hit more than 2,000 users[^tmus-outage-20260707]. And in the middle of that split analyst decision, T-Mobile also lost a 28-year veteran — Chief Business and Product Officer Mike Katz stepped down, staying on only as an advisor through December[^tmus-katz-exit-20260707]. Marcus — who’s actually right here?

Marcus: T-Mobile’s the only one of these three actually growing into its number. Just under 16 times trailing free cash flow, and free cash flow’s up 6% year over year — not down, up[^memo-tmus-evfcf-20260331][^memo-tmus-growth-20260331]. Management’s still buying back stock, $12 billion trailing twelve months[^memo-tmus-buyback-20260331]. That’s not a balance sheet bracing for a satellite hit. Bank of America and Wells Fargo disagree because the numbers genuinely don’t show the damage yet at T-Mobile — the disagreement is really about which cable and wireless name gets hit first, and right now T-Mobile’s cash flow statement is voting with BofA.

Ava: Verizon’s in the same boat, for what it’s worth — Wells Fargo started coverage there this week too, same Starlink logic, same Equal Weight[^vz-wells-fargo-equal-weight-20260708]. Three telecom names, one satellite story, and completely different balance sheets underneath it. Same page of the memo, three different answers to the same question.

Deep dive — Micron vs. Intel

Ava: The deep dive this week is page 3 of the memo — Micron and Intel. Same industry, same seven days, opposite direction entirely. Both companies make chips. Both are spending tens of billions on U.S. manufacturing. And this week, one of them got paid for it and the other got punished for it. One company just told the market it’s betting a quarter-trillion dollars on a supercycle that isn’t slowing down. The other just watched its oldest rival pass it in the one number that was supposed to be safe.

Ava: Micron raised its U.S. manufacturing commitment to $250 billion through 2035 — $50 billion more than the number it announced earlier this year — and poured first concrete at its new fab in Clay, New York, more than a full quarter ahead of schedule[^mu-investment-expansion-20260709][^mu-nyc-fab-concrete-20260709]. It also put another $3 billion into the domestic supply chain this week, including financing to GlobalWafers for a Texas wafer facility[^mu-supply-chain-20260709]. Intel had a rougher week — and it actually started on a high note. Intel stock got an early lift Monday when the Broadcom-Apple chip deal triggered a broader semiconductor rally, up 5% on the read-through[^intc-broadcom-apple-20260706]. That lift didn’t last. Reports surfaced that its 18A and 18A-P manufacturing nodes won’t hit profitable yields until late 2026 at the earliest — more likely 2027[^intc-stock-decline-20260708]. The stock dropped nearly 10% on July 7, another almost 8% on July 8 — a 21% decline in seven trading days[^intc-stock-decline-20260708]. And in the same window, AMD reported more first-quarter data-center revenue than Intel for the first time ever — $5.8 billion to Intel’s $5.1 billion[^intc-amd-datacenterdominance-20260708]. Marcus, start with Micron.

Marcus: Micron just re-priced itself without anyone noticing, because the earnings caught up to the multiple instead of the multiple getting cut. The memo has Micron at about 41 times trailing free cash flow now, on $26 billion of trailing FCF — up about 879% from a year ago[^memo-mu-evfcf-20260528][^memo-mu-growth-20260528]. That’s not a stock getting more expensive. That’s a company whose cash generation exploded faster than the stock price did. The pledge increase and the ahead-of-schedule fab are Micron telling you it believes this isn’t a one-quarter DRAM spike. Watch whether pricing holds through the next print — that’s the whole bet.

Ava: Now the other side of that page.

Marcus: Intel didn’t lose the data-center chip war on a spreadsheet — it lost it on a delayed process node. Capex ran about $13 billion trailing twelve months[^memo-intc-capex-20260328], and none of that spending has translated into a profitable 18A yield yet, which is why free cash flow is negative and there’s no honest multiple to put on this stock right now. The number that actually matters isn’t a valuation ratio — it’s $5.8 billion versus $5.1 billion, AMD over Intel in data-center revenue, a line that has never crossed before[^intc-amd-datacenterdominance-20260708]. The test isn’t the next earnings beat. It’s whether 18A actually yields profitably on the 2027 timeline this report just laid out.

Marcus: Same memo page, same week. One company’s balance sheet just got permission to spend more. The other’s still waiting on a process node that isn’t yielding yet.

Ava: Micron’s betting on being early. Intel’s betting on catching up. Mark the next print for both.

Rapid-fire

Ava: Rapid-fire. Two more stories this week, no deep analytical beat — just the signal, quick.

Ava: NextEra Energy filed the paperwork on the biggest utility merger of the year. The SEC S-4 went in on July 9 — roughly $67 billion, NextEra absorbing Dominion Energy, each Dominion share converting into NextEra stock plus a cash payment, targeting close in the second half of 2027[^nee-dominion-s4-20260709]. Here’s the tension: the Cash Flow Memo already had NextEra’s free cash flow down 65% year over year before any of this[^memo-nee-growth-20260331]. They’re announcing the sector’s largest deal in years off a balance sheet that’s already stretched. NextEra reports its own second-quarter numbers on July 24[^nee-earnings-date-20260710] — that’s the print to watch for how this financing actually gets structured.

Ava: Apple and Broadcom extended their chip partnership through 2031 — $30 billion, more than 15 billion U.S.-made chips, including a $1.5 billion facility expansion in Fort Collins, Colorado[^aapl-avgo-chipdeal-20260708]. Apple’s already sitting at about 35 times trailing free cash flow[^memo-aapl-evfcf-20260328] — this is a company paying up for supply-chain certainty, not hunting for a cheap deal. Same week, the EU’s top court rejected Apple’s appeal and upheld its gatekeeper designation under the Digital Markets Act, for both iOS and the App Store[^aapl-eu-antitrust-20260708]. Broadcom, on the other side of the chip deal, got downgraded to Hold by Erste Group — their read is a 35-times forward multiple against Nvidia’s 22, even with the strong margins[^avgo-downgrade-20260707]. One company paying for certainty, one company getting told its certainty is already priced in. Apple’s own Q3 print lands July 30, off guidance of 14–17% revenue growth on iPhone 17 demand[^aapl-q3-call-20260709] — that’s the number that tells you whether paying for certainty was worth it.

Close

Ava: That’s the show. Wall Street’s consensus on cable and wireless: satellites are coming for all three names the same way. Two banks agree on Comcast and Charter — but Bank of America just broke ranks on T-Mobile, and this week T-Mobile’s own cash flow statement backed them up. Consensus isn’t as unanimous as the headlines make it sound. And on chips: consensus likes to treat memory and logic as the same semiconductor story. Micron and Intel just spent a week proving they’re not — one’s compounding, the other’s now pricing in a 2027 turnaround instead of a 2026 one.

Ava: Forward week: earnings season builds fast. JPMorgan and Goldman Sachs both report Tuesday[^earn-jpm][^earn-gs] — the first real read on how the banks are pricing credit risk into the back half of the year. ASML drops Wednesday, and Morgan Stanley reports the same day[^earn-asml][^earn-ms]. Thursday is stacked — Taiwan Semi, Netflix, and UnitedHealth, all in one session[^earn-tsm][^earn-nflx][^earn-unh]. Taiwan Semi in particular is the real test of whether Micron’s supercycle story extends to the rest of the chip complex, or stays a memory-only story. Hunt, Jason, and Mike are back Wednesday on episode E2629. Download the Cash Flow Memo at telltales.us.

Closing disclaimer

Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.

Sources

* AMD Tops Intel in Q1 Data Center Revenue on AI Demand. (2026, July 8). WinBuzzer. https://winbuzzer.com/2026/05/08/analysis-amd-overtakes-intel-in-data-center-revenu-xcxwbn/

* Apple Inc. (2026, July 8). Apple to increase spend with Broadcom to produce billions more U.S. chips [Press release]. Apple Newsroom. https://www.apple.com/newsroom/2026/07/apple-to-increase-spend-with-broadcom-to-produce-billions-more-us-chips/

* Apple loses major antitrust appeal in Europe, remains a gatekeeper. (2026, July 8). 9to5Mac. https://9to5mac.com/2026/07/08/apple-loses-major-antitrust-appeal-in-europe-remains-a-gatekeeper/

* Apple schedules Q3 2026 earnings conference call for July 30th. (2026, July 9). MacDailyNews. https://macdailynews.com/2026/07/09/apple-schedules-q3-2026-earnings-conference-call-for-july-30th/

* Barclays Adjusts Price Target on Charter Communications to $130 From $200. (2026, July 8). MarketScreener. https://www.marketscreener.com/news/barclays-adjusts-price-target-on-charter-communications-to-130-from-200-ce7f5ed9d88ef222

* Broadcom Expands Work for Apple Supplying Products through 2031. (2026, July 6). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-06/broadcom-expands-work-for-apple-supplying-products-through-2031

* Charter Communications to discontinue Network Operations Center team at Town & Country office. (2026, July 9). First Alert 4. https://www.firstalert4.com/2026/07/09/warn-notice-released-charter-town-country/

* Comcast Corporation. (2026, July 7). Comcast Reaches Construction Milestone in Greater Phillipsburg Expansion, Bringing Xfinity and Comcast Business Services to More New Jersey Communities [Press release]. Business Wire. https://www.businesswire.com/news/home/20260707307752/en/Comcast-Reaches-Construction-Milestone-in-Greater-Phillipsburg-Expansion-Bringing-Xfinity-and-Comcast-Business-Services-to-More-New-Jersey-Communities

* CPUC Judge Proposes Approving Charter-Cox Merger. (2026, July 9). Broadband Breakfast. https://broadbandbreakfast.com/cpuc-judge-proposes-approving-charter-cox-merger/

* Erste Group Moves Broadcom (AVGO) to Hold. (2026, July 7). Yahoo Finance. https://finance.yahoo.com/news/erste-group-moves-broadcom-avgo-164525932.html

* ITV agrees sale of media and entertainment business to Sky for up to £1.6bn. (2026, July 6). ITV News. https://www.itv.com/news/2026-07-06/itv-agrees-sale-of-media-and-entertainment-business-to-sky-for-up-to-16bn

* Micron Boosts US Spending to $250 Billion to Feed Memory Boom. (2026, July 9). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-09/micron-boosts-us-spending-to-250-billion-amid-memory-demand

* Micron Technology, Inc. (2026, July 9). Micron Accelerates U.S. Investments, Pours First Concrete at New York Fab [Press release]. GlobeNewswire. https://www.globenewswire.com/news-release/2026/07/09/3324807/14450/en/Micron-Accelerates-U-S-Investments-Pours-First-Concrete-at-New-York-Fab.html

* Morgan Stanley Adjusts Price Target on Comcast to $30 From $33. (2026, July 7). MarketScreener. https://www.marketscreener.com/news/morgan-stanley-adjusts-price-target-on-comcast-to-30-from-33-ce7f5edbd08cf624

* NextEra Energy, Inc. (2026, July 9). NextEra Energy and Dominion Energy to merge [Form S-4]. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/0000753308/000110465926082301/tm2614888-13_s4.htm

* NextEra Energy, Inc. (2026, July 10). NextEra Energy announces date for release of second-quarter 2026 financial results [Press release]. PR Newswire via TradingView News. https://www.tradingview.com/news/prnewswire:3f783c3848b02:0-nextera-energy-announces-date-for-release-of-second-quarter-2026-financial-results/

* Semiconductor Selloff Deepens As AI Spending Fears Hit Intel. (2026, July 8). Forbes. https://www.forbes.com/sites/petercohan/2026/07/08/intel-stock-down-21-inside-the-july-2026-semiconductor-selloff/

* T-Mobile Down for Thousands of Users, Downdetector Shows. (2026, July 7). GV Wire. https://www.gvwire.com/2026/07/07/t-mobile-down-for-thousands-of-users-downdetector-shows/

* T-Mobile US, Inc. (2026, July 7). T-Mobile Appoints Chris Sambar Chief Enterprise Officer and Evolves Leadership Team to Advance its Next Era of Strategic Growth and Innovation [Press release]. T-Mobile Newsroom. https://www.t-mobile.com/news/business/t-mobile-appoints-chris-sambar-chief-enterprise-officer

* T-Mobile stock gains as BofA upgrades to Buy, says satellite fears overblown. (2026, July 6). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/t-mobile-stock-gains-bofa-121406811.html

* Wells Fargo cautious on AT&T, Verizon and T-Mobile as Starlink looms. (2026, July 8). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/wells-fargo-cautious-t-verizon-123610956.html

* Wells Fargo initiates T-Mobile stock coverage with Equal Weight rating. (2026, July 8). Investing.com. https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-tmobile-stock-coverage-with-equal-weight-rating-93CH-4781310

* Wells Fargo Maintains Underweight on Charter Communications, Lowers Price Target to $160. (2026, July 7). Sahm Capital. https://www.sahmcapital.com/news/content/wells-fargo-maintains-underweight-on-charter-communications-lowers-price-target-to-160-2026-07-07

Earnings slate references

Earnings dates sourced from the W2628 earnings slate (04. Publishing/shows/weekend-update/W2628/dryrun/earnings_slate.md), pulled 2026-07-10.

* JPMorgan Chase (JPM) — 2026-07-14 (Tuesday), consensus EPS $5.52, consensus revenue $51.06B

* Goldman Sachs (GS) — 2026-07-14 (Tuesday), consensus EPS $14.47, consensus revenue $16.22B

* ASML (ASML) — 2026-07-15 (Wednesday), consensus EPS $7.98, consensus revenue $10.26B

* Morgan Stanley (MS) — 2026-07-15 (Wednesday), consensus EPS $2.89, consensus revenue $19.65B

* Taiwan Semiconductor (TSM) — 2026-07-16 (Thursday), consensus EPS $3.80, consensus revenue $39.97B

* Netflix (NFLX) — 2026-07-16 (Thursday), consensus EPS $0.79, consensus revenue $12.58B

* UnitedHealth (UNH) — 2026-07-16 (Thursday), consensus EPS $4.84, consensus revenue $110.76B

Internal data

Internal data is provided on a best efforts basis.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Oil holds steady despite Hormuz drone strikes, SK Hynix tests a $25B US listing, and the team runs its mid-year predictions scorecard across energy, tech, and healthcare — including Vertex’s $10B endocrine bet and Palantir’s Karp taking on Anthropic and OpenAI.

The Cashflow Memo

The Prediction Scorecard

https://telltales.topmarkcapital.com/predictions/

Key Takeaways

* Despite Hormuz drone strikes on three ships, Hunt sees no material oil supply disruption — crude drifts to the high-$70s (vs. high-$60s) while natural gas holds flat near $3.50 through 2027, and Medicare/Medicaid (~$2T of $7T federal spending) remains the only credible deficit lever.

* SK Hynix is raising $25B in the US equity market ahead of a July 10 listing, reviving Hunt’s overbuild concerns for memory (Samsung/Hynix/Micron); IBM’s 7-angstrom (0.7nm) research chip claims a density lead over TSMC’s current 2nm node (1.6nm planned for next year).

* The Nvidia-Palantir open-source JV (government first, banks next) reflects Jason’s models are commodity thesis; Alex Karp’s CNBC appearance pressed Anthropic and OpenAI on enterprise data trust, positioning Palantir’s context-graph as the model-agnostic integration layer.

* Predictions scorecard: 2026 pharma M&A tracks to a record pace (~$150B in H1, ahead of 2019, driven by deal volume not mega-deals — largest single transaction only $13B); Tesla Robotaxi needs a serious hockey stick to catch Waymo given still-thin Austin/Miami fleets; xAI’s Grok 4.5 (claimed near-Opus-4.7 quality, cheaper/faster, but only 500K context) keeps the xAI leads call alive.

* Vertex is paying ~$10B for Kynetix (San Diego endocrine-disorder pipeline, one drug already FDA-approved) on a bet that microplastic-driven endocrine disease is a growing secular market; CMS now projects US healthcare spend hits $9T (21% of GDP) by 2034.

Show Notes

[00:00:00] Intro & Welcome Mike opens the show; download this week’s Cash Flow Memo at telltales.us.

[00:00:26] Exhibit C: Oil, Gas & Hormuz Risk Hunt argues the Hormuz drone strikes won’t meaningfully dent oil supply; he sees prices drifting into the high-$70s while natural gas holds flat near $3.50 through 2027.

[00:04:23] Exhibit A: The Deficit, Defense Spending & Medicare Defense spending rises in FY27, interest costs hold near 3.5%, and Hunt makes the case for a bipartisan Medicare-for-All push to rationalize the ~$2 trillion Medicare/Medicaid budget.

[00:06:18] Tech News: SK Hynix’s $25B Listing & IBM’s 7-Angstrom Chip SK Hynix raises $25B in the US ahead of a July 10 listing, raising overbuild concerns in memory; IBM claims a density lead over TSMC with a 7-angstrom (0.7nm) research chip.

[00:09:23] Palantir, Karp’s CNBC Meltdown & the AI Trust War Alex Karp challenges Anthropic and OpenAI on enterprise data trust; Mike breaks down Palantir’s context-graph pitch as the model-agnostic integration layer for the enterprise, alongside its custom-model partnership with Nvidia.

[00:13:17] Predictions Review: Energy & Nuclear US gas supply prediction hits 108 bcf/d; TerraPower’s Wyoming construction permit keeps the Gen IV nuclear call on track, while $4.50-5 natural gas and China oil demand growth both stall out.

[00:16:21] Predictions Review: Tech, Robotaxis & Quantum Risk to Bitcoin Tesla Robotaxi needs a serious hockey stick to catch Waymo’s ride volume; new Google research shrinks the qubit count needed to crack Bitcoin encryption, pulling forward the threat timeline.

[00:21:43] Predictions Review: Healthcare, Pharma M&A & GLP-1s 2026 pharma M&A tracks to a record ~$150B first half; Vertex pays ~$10B for endocrine-disorder specialist Kynetix, and a new Medicare GLP-1 bridge program offers $50/month prescriptions through year-end.

[00:30:06] Wrap-Up Hunt and the team close out the predictions review largely unscathed.

Get the full Cash Flow Memo with updated financials on ~80 companies at telltales.us — new episodes every week. Track how our calls are actually playing out at our predictions scorecard.

Cashtags

$AAPL $AMZN $GOOGL $LLY $MSFT $MU $NVDA $PLTR $TSLA $TSM $VRTX

This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com